Fungicidal composition

methyl (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate and biphenylpyrazone in a specific fungicidal composition The mixture of ingredients such as amines solves the problem of poor control of plant pathogenic fungi in the prior art, achieves higher biological activity and safety, and reduces the frequency of application and environmental impact.

CN118975562AActive Publication Date: 2024-11-19SYNGENTA CROP PROTECITON AG
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410797293.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2020-12-18
Filing Date
2021-03-05
Publication Date
2024-11-19
Estimated Expiration
2041-03-05

AI Technical Summary

Technical Problem

Existing fungicidal compounds and compositions are not satisfied with the control effect of plant pathogenic fungi in agricultural practice, especially in terms of biological activity, activity spectrum, safety and environmental impact, and the application frequency is high, and the operator is exposed. High risk.

Method used

A fungicidal composition consisting of a mixture of a compound of formula (I) and a variety of fungicidal active ingredients, including components (A) and (B), wherein component (A) is (Z )-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate or its salt, component (B) is biphenopyramidine , chloroprotinate, cyclozolin, etc., are mixed in a specific proportion to fight against plant pathogenic fungi.

Benefits of technology

The composition significantly improves the bioactivity and activity spectrum against plant pathogenic fungi, enhances safety and biodegradability, reduces application frequency and environmental impact, and improves the tolerance and protection effect of crops.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

Disclosed is a fungicidal composition comprising a mixture of components (A) and (B) wherein components (A) and (B) are as defined in claim 1, and the use of said composition in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of Chinese invention patent application No. 202180018462.4, with the invention name of "Fungicide Composition", the application date of which is March 5, 2021, and the earliest priority date is March 5, 2020.

[0002] The present invention relates to novel fungicidal compositions, to their use in agriculture or horticulture for controlling diseases caused by phytopathogens, especially phytopathogenic fungi, and to methods for controlling diseases on useful plants.

[0003] Although many fungicidal compounds and compositions belonging to a variety of different chemical classes have been developed or are being developed for use as fungicides in crops of useful plants, in many respects, crop tolerance and activity against specific phytopathogenic fungi do not always meet the needs of agricultural practice. Therefore, there is a continuing need to discover new compounds and compositions with superior biological properties for use in controlling or preventing infection of plants by phytopathogenic fungi. For example, compounds with greater biological activity, a favorable spectrum of activity, increased safety, improved physicochemical properties, increased biodegradability. Or in addition, compositions with a broader spectrum of activity, improved crop tolerance, improved synergistic interactions or enhanced properties, or compositions that show a more rapid onset of action or have a longer lasting residual activity or that can reduce the number of applications and / or reduce the application rate of compounds and compositions required for effective control of phytopathogenic fungi, thereby enabling beneficial tolerance management practices, reduced environmental impacts and reduced operator exposure.

[0004] Some of these needs may be addressed using compositions comprising mixtures of different fungicidal compounds having different modes of action (eg by combining fungicides having different activity spectra).

[0005] According to the present invention, there is provided a fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is a compound having formula (I)

[0006]

[0007] in

[0008] R 1 It is methyl;

[0009] R 2 It is hydrogen;

[0010] R 3 It is hydrogen;

[0011] R 4 is a C3-C7 cycloalkyl group;

[0012] or an agronomically acceptable salt thereof;

[0013] and

[0014] Component (B) is a compound selected from the group consisting of:

[0015] Bixafen, sulfur, copper hydroxide, chlorpyrifos, acibenzolar-S-methyl, copper oxychloride, cyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole, ipconazole, metconazole, paclobutrazol, prothioconazole, prochloraz, propiconazole, pyraclostrobin, tebuconazole, fenpropidin, fenpropimorph, spiroxaplanol, cyprodinil, fludioxonil, metalaxyl, metalaxyl-M, carbendazim, penthiopyrad, azoxystrobin, etherstrobin, enoxadone, flutolanil, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, fluazinam, flupyraclostrobin , fenhexamid, fosetyl-aluminium, pyrimidine, tricyclazole, mandipropamid, fluphenazine, isopyrazam, sedaxane, benzovintriazole, fluopyramide, isoflurane, isoflurane, dipymetitrone, fluindapyr, jiaxiangjunzhi, lvbenmixianan, mandestr obin), oxathiapiprolin, pyraziflumid, inpyrfluxam, clofoconazole, ipfentrifluconazole, aminopyrifen, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, pyridine, fenpicoxamid, ipflufenoquin, quinofolin, inofumelin), benzathiostrobin, fluopyram, pyrapropoyne, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, metyltetraprole, fluoxapiprolin, enoxastrobin, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, trinexapac, trinexapac-ethyl, syringoxystrobin, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, Chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-isopropyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl] -N-isopropyl-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine, N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] oxazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester , N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, 1-[[5-[5-(trifluoromethyl)-1, 2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylic acid ethyl ester, 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N-[N-methoxy-C-methyl-carbonimido]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N-[3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl]-5-methyl-1,2,4-oxadiazole-3-carboxamide, 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine-3-carboxamide, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl](2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propionate, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl](2S)-2-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]propionate, cis-jasmone, potassium phosphonate, calcium phosphonate, glyphosate (including its diammonium, isopropylammonium and potassium salts), 2,4-D (including its choline salt and 2-ethylhexyl ester), dicamba (including its aluminum, aminopropyl, bis-aminopropyl methyl , choline, 1,3-dichloropropene (dichloroprop), diglycolamine, dimethylamine, dimethylammonium, potassium and sodium salts), glufosinate (including its ammonium salt), thiamethoxam, cyclobutrifluram, isoxathiapiprolin, spiropidion, avermectin, emamectin, cyantraniliprole, chlorantraniliprole, diafenthiuron, broflanilide, 2-chloro-N-cyclopropyl-5-(1-{2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-1H-pyrazol-4-yl)-N-methylnicotinamide and fluxametamide.

[0016] Generally, the weight ratio of component (A) to component (B) may preferably be from 100:1 to 1:100, from 50:1 to 1:50, from 20:1 to 1:50, from 15:1 to 1:50, from 15:1 to 1:30, from 12:1 to 1:25, from 10:1 to 1:20, from 5:1 and 1:15, from 3:1 to 1:10 or from 2:1 to 1:5.

[0017] According to the present invention, there is also provided a method for controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi, on useful plants or their propagation materials, which method comprises applying the fungicidal composition according to the invention to these useful plants, their loci or their propagation materials.

[0018] The benefits provided by certain fungicidal mixture compositions according to the present invention may also include, among other things, favorable levels of biological activity for protecting plants against diseases caused by fungi or superior properties for use as agrochemical active ingredients (e.g., greater biological activity, a favorable spectrum of activity, increased safety, improved physico-chemical properties, or increased biodegradability).

[0019] For the substituent R in the compound having formula (I) 1 , R2 , R 3 and R 4 Preferred groups and values, in any combination thereof, are as listed below.

[0020] R 1 It's methyl.

[0021] R 2 It's hydrogen.

[0022] R 3 It's hydrogen.

[0023] R 4 It is a C3-C7 cycloalkyl group.

[0024] Preferably, component (A) is a compound selected from the following:

[0025] (Z)-2-(5-Cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0026] (Compound X.01),

[0027] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0028] (Compound X.02),

[0029] (Z)-2-(5-Cyclopropyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0030] (Compound X.03), or

[0031] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0032] (Compound X.04), as defined in Table X below.

[0033] More preferably, component (A) is a compound selected from the group consisting of,

[0034] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0035] (Compound X.02), or

[0036] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0037] (Compound X.04), as defined in Table X below.

[0038] In one embodiment, component (A) is (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.02).

[0039] In another embodiment, component (A) is (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.04).

[0040] Table X

[0041]

[0042]

[0043] Component (B) is a compound selected from the group consisting of:

[0044] Bixafen, sulfur, copper hydroxide, chlorpyrifos, acibenzolar-S-methyl, copper oxychloride, cyproconazole, difenoconazole, fluconazole, flutriafol, hexaconazole, cyproconazole, metconazole, paclobutrazol, prothioconazole, prochloraz, propiconazole, pyraclostrobin, tebuconazole, fenpropidin, fenbutrazole, spiroxafil, cyprodinil, fludioxonil, metalaxyl, metalaxyl-M (metalaxyl-M Ling), carbendazim, penthiopyrad, azoxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, fluazinam, flupyraclostrobin, fenhexamid, fosetyl-aluminum, pyraclostrobin, tricyclazole, dimethomorph, fluphenazine, pyraclostrobin, pyraclostrobin, Naphthoclopol, fluoxazolidinone, benzovinflumizone, fluoxazolidinone, isoflurane, isothiocarbamide, difenazol, fluoxazolidinone, chloranil, rubenmisian, mandespin, fluthiazolinone, bifenthiazolin, empelforsam, chlorfluazol, isofantafonazole, aminopyrifen, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, pyridine, fenpicomedone, flubenquin, quinofolin, benzothiocarb, fluopyram, pyrrolidine, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide, 4-[[6-[2-(2,4-di [[(6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thio-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, methotrexate, flupiperidin, enoxamyl, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thio-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, trifloxylic acid, trifloxylic acid, syringystrobin, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3 -pyridinyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-isopropyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,N-(2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine, N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl amine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propionate, 1-methoxy-3-methyl-1-[[4-[5 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4 -[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylic acid ethyl ester, 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N -[N-methoxy-C-methyl-carbonimido]-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide, N-[3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl]-5-methyl-1,2,4-oxadiazole-3-carboxamide, 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine-3-carboxamide, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl] (2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino] propionate, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl] (2S)-2-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]propionate, cis-jasmone, potassium phosphonate, calcium phosphonate, glyphosate (including its diammonium, isopropylammonium and potassium salts), 2,4-D (including its choline salt and 2-ethylhexyl ester), dicamba (including its aluminum, aminopropyl, bis-aminopropylmethyl, choline, 1,3-dichloropropylene, diglycolamine, dimethylamine, dimethylammonium, potassium and sodium salts), glufosinate (including its ammonium salt), thiamethoxam, cypermethrin, isoxathiapiprolin, ethyl methoxypiperidin, avermectin, emamectin, cyantraniliprole, chlorantraniliprole, diafenthiuron, bromofenac, 2-chloro-N-cyclopropyl-5-(1-{2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-1H-pyrazol-4-yl)-N-methylnicotinamide and fluorooxazoleamide.

[0045] Preferably, component (B) is a compound selected from the group consisting of bixafen, sulfur, copper hydroxide, chlorpyrifos, acibenzolar-S-methyl, copper oxychloride, cyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole, ipconazole, metconazole, paclobutrazol, prothioconazole, prochloraz, propiconazole, pyraclostrobin, tebuconazole, fenpropidin, fenpropimorph, spiroxaplanol, cyprodinil, fludioxonil, metalaxyl, metalaxyl-M (metalaxyl-M), carbendazim, penthiopyrad , azoxystrobin, ethersstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, oxathiocarb, pyraclostrobin, pyraclostrobin, mancozeb, folpet, chlorothalonil, fluazinam, flupyraclostrobin, fenacet, fosetyl-aluminum, pyraclostrobin, tricyclazole, mancozeb, oxathiocarb, flutoxin, fenacet, triethyl-aluminum, pyraclostrobin, tricyclazole, mancozeb, pyraclostrobin, flutoxin, fenacet, pyraclostrobin, tricyclazole, mancozeb, pyraclostrobin, flutoxin, fenacet, pyraclostrobin, triethyl-aluminum, pyraclostrobin, tricyclazole, mancozeb, pyraclostrobin, flutoxin, fenacet, pyraclostrobin, flutoxin, fenacet, pyraclostrobin, flutoxin, Asteroxystrobin, Rubenmisian, Mandespin, fluthiazolin, bifenthiazolin, Imperfusam, chlorfluanidazole, isofantifen, aminopilifen, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, pyridine, fenpicomedone, flubenquin, quinofolin, benzathiostrobin, fluopyram, pyriproxystrobin, 2-(difluoromethyl)-N- (3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridinyl]oxy]benzonitrile, methotrexate, flupiperidin, enoxastrobin, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thio-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, trinexapac-ethyl, trinexapac-ethyl, syringostyrin, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-isopropyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4 -[2-trifluoromethyl)oxetane-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[[4-[ 5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-( 1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, ( 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate, 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N- [N-methoxy-C-methyl-carbonimido]-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide, N-[3-(4-chlorophenyl)-4,5-dihydroisoxazol-5-yl]-5-methyl-1,2,4-oxadiazole-3-carboxamide, 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-indan-4-yl)pyridine-3-carboxamide, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl] (2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl](2S)-2-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]propionate, cis-jasmone, potassium phosphonate, calcium phosphonate, glyphosate (including its diammonium, isopropylammonium and potassium salts), 2,4-D (including its choline salt and 2-ethylhexyl ester), dicamba (including its aluminum, aminopropyl, bis-aminopropylmethyl, choline, 1,3-dichloropropylene, diglycolamine, dimethylamine, dimethyl ammonium, potassium and sodium salts), glufosinate (including its ammonium salt), thiamethoxam, cypermethrin, isoxathiapiprolin, methoxyphene ethyl, avermectin, emamectin, cyantraniliprole, chlorantraniliprole, diafenthiuron, bromofenac, 2-chloro-N-cyclopropyl-5-(1-{2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-1H-pyrazol-4-yl)-N-methylnicotinamide and fluoxathiapiprolin.

[0046] More preferably, component (B) is a compound selected from the group consisting of bixafen, chlorpyrifos, cyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole, ipconazole, metconazole, prothioconazole, propiconazole, tebuconazole, azoxystrobin, ethersstrobin, enoxadone, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopyram, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopyram, pyraclostrobin, benzovintrifloxystrobin, isoflurane, jiaxiangjunzhi, mandestrobin, chlorpyrifos, ipfentrifloxystrobin, flutoxin ... zole), benzathiostrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile.

[0047] Even more preferably, component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopyram, benzovintriazole, isoflurane, and metyltetraprole.

[0048] Yet even more preferably, component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, and methotrexate.

[0049] Still more preferably, component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, prothioconazole, azoxystrobin, trifloxystrobin, pyraclostrobin, and metyltetraprole.

[0050] Furthermore, it is also preferred that component (B) is azoxystrobin or trifloxystrobin.

[0051] Most preferably, component (B) is azoxystrobin.

[0052] In one embodiment, component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, fenpropidin, fenpropimorph, fludioxonil, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, fluopicolide, benzovinflumazole, isoflurane, fluopicolide, clofopyralid, pyraclostrobin, methotrexate, N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, and [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propionate. Preferably, component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, prothioconazole, fenpropidin, fenpropimorph, fludioxonil, azoxystrobin, trifloxystrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, benzovinfluazide, fluopicolide, clofopyralid, pyraclostrobin, pyraclostrobin, methotrexate, N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, and [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate.

[0053] These component (B) compounds are referred to herein and above by the so-called "ISO common name" or another "common name" or trade name used in individual cases. These component (B) compounds are known and are commercially available and / or can be prepared using procedures known in the art and / or reported in the literature.

[0054] In a preferred composition according to the present invention, component (A) is compound No. X.01 (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, picroconazole, metconazole, prothioconazole, propiconazole, pentamazole alcohol, azoxystrobin, ethersstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, oxathiocarb, oxathiocarb, picoxystrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, flutoxin, pyraclostrobin, benzovinfluconazole, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluazuril, ipfentrifluconazole, benzathiostrobin, metyltetraprole, enoxastrobin, syringostyrin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2- (Trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0055] In another preferred composition according to the present invention, component (A) is compound No. X.02 (Z) -2- (5-cyclopentyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole , tebuconazole, azoxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, flutoxin, pyraclostrobin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluazuron , ipfentrifluconazole, benzathiostrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2 -(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0056] In another preferred composition according to the present invention, component (A) is compound No. X.03 (Z) -2- (5-cyclopropyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole , tebuconazole, azoxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, flutoxin, pyraclostrobin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluazuron , ipfentrifluconazole, benzathiostrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2 -(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0057] In another preferred composition according to the present invention, component (A) is compound No. X.04 (Z) -2- (5-cyclohexyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole , tebuconazole, azoxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, flutoxin, pyraclostrobin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluazuron , ipfentrifluconazole, benzathiostrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2 -(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0058] In a more preferred composition according to the present invention, component (A) is compound No. X.01 (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0059] In a more preferred composition according to the present invention, component (A) is compound No. X.02 (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0060] In a more preferred composition according to the present invention, component (A) is compound No. X.03 (Z)-2-(5-cyclopropyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0061] In a more preferred composition according to the present invention, component (A) is compound No. X.04 (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:50.

[0062] In a preferred composition according to the present invention, component (A) is compound No. X.01 (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: bixafen, chlorpyrifos, cyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole, tebuconazole, azoxystrobin , ethersstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, mancozeb, thiophanate-methyl, flutoxin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluazifop, ipfe ntrifluconazole), benzathiostrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1- (1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0063] In another preferred composition according to the present invention, component (A) is compound No. X.02 (Z) -2- (5-cyclopentyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of bixafen, chlorpyrifos, cyproconazole, difenoconazole, epoxiconazole, flutriafol, hexaconazole, picroconazole, metconazole, prothioconazole, propiconazole, tebuconazole, pyrimidine oxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, chlorothalonil, flutoxin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluanid, isoflurane, ip fentrifluconazole), benzathiastrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1 -(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0064] In another preferred composition according to the present invention, component (A) is compound No. X.03 (Z) -2- (5-cyclopropyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole, tebuconazole, pyrimidine oxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, chlorothalonil, flutoxin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluanid, isoflurane, ip fentrifluconazole), benzathiastrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1 -(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0065] In another preferred composition according to the present invention, component (A) is compound No. X.04 (Z) -2- (5-cyclohexyl-2-methyl-phenoxy) -3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of bixafen, chlorpyrifos, cyproconazole, difenoconazole, flucycloconazole, flutriafol, hexaconazole, cyproconazole, metconazole, prothioconazole, propiconazole, tebuconazole, pyrimidine oxystrobin, etherstrobin, enoxastrobin, flutoxin, fluoxastrobin, fenoxystrobin, trifloxystrobin, trifloxystrobin, pyraclostrobin, pyraclostrobin, mancozeb, chlorothalonil, flutoxin, pyraclostrobin, benzovinflucypram, isoflurane, jiaxiangjunzhi, mandestrobin, chlorfluanid, isoflurane, ip fentrifluconazole), benzathiastrobin, metyltetraprole, enoxastrobin, syringystrobin, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridinyl]-1 -(1,2,4-triazol-1-yl)propan-2-ol, 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, and 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0066] In a preferred composition according to the present invention, component (A) is compound No. X.01 (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0067] In another preferred composition according to the present invention, component (A) is compound No. X.02 (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0068] In another preferred composition according to the present invention, component (A) is compound No. X.03 (Z)-2-(5-cyclopropyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0069] In another preferred composition according to the present invention, component (A) is compound No. X.04 (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, thiophanate-methyl, fluopicolide, benzovintriazole, isoflurane and methotrexate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0070] In a preferred composition according to the present invention, component (A) is compound No. X.01 (Z)-2-(5-cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, prothioconazole, azoxystrobin, trifloxystrobin, pyraclostrobin, and metyltetraprole, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0071] In another preferred composition according to the present invention, component (A) is compound No. X.02 (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, prothioconazole, azoxystrobin, trifloxystrobin, pyraclostrobin, and metyltetraprole, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0072] In another preferred composition according to the present invention, component (A) is compound No. X.03 (Z)-2-(5-cyclopropyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, prothioconazole, myclobutanil, trifloxystrobin, pyraclostrobin, and metyltetraprole, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0073] In another preferred composition according to the present invention, component (A) is compound No. X.04 (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester or its salt or tautomer, and component (B) is a compound selected from the group consisting of: cyproconazole, difenoconazole, prothioconazole, myclobutanil, trifloxystrobin, pyraclostrobin, and metyltetraprole, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0074] In one embodiment of the present invention, there is provided a synergistic fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0075] (Z)-2-(5-Cyclobutyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0076] (Compound X.01),

[0077] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0078] (Compound X.02),

[0079] (Z)-2-(5-Cyclopropyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0080] (Compound X.03), or

[0081] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0082] (Compound X.04),

[0083] or an agronomically acceptable salt thereof;

[0084] and

[0085] Component (B) is a compound selected from the group consisting of:

[0086] Cyproconazole, difenoconazole, prothioconazole, azoxystrobin, trifloxystrobin, pyraclostrobin, and metyltetraprole.

[0087] Preferably, in an embodiment of the present invention, a synergistic fungicidal composition is provided, comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0088] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0089] (Compound X.02), or

[0090] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0091] (Compound X.04);

[0092] or an agronomically acceptable salt thereof;

[0093] and

[0094] Component (B) is a compound selected from the group consisting of:

[0095] Cyproconazole, difenoconazole, prothioconazole, azoxystrobin, trifloxystrobin, pyraclostrobin, and metyltetraprole, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0096] More preferably, in an embodiment of the present invention, there is provided a synergistic fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0097] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0098] (Compound X.02), or

[0099] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0100] (Compound X.04);

[0101] or an agronomically acceptable salt thereof;

[0102] and

[0103] Component (B) is azoxystrobin or trifloxystrobin, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0104] Even more preferably, in an embodiment of the present invention, there is provided a synergistic fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0105] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0106] (Compound X.02), or

[0107] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0108] (Compound X.04);

[0109] or an agronomically acceptable salt thereof;

[0110] and

[0111] Component (B) is azoxystrobin, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 7.5:1 to 1:7.5).

[0112] In another preferred embodiment of the present invention, there is provided a synergistic fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0113] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0114] (Compound X.02), or

[0115] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0116] (Compound X.04);

[0117] or an agronomically acceptable salt thereof;

[0118] and

[0119] Component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, hexaconazole, prothioconazole, propiconazole, fenpropidin, fenpropimorph, fludioxonil, azoxystrobin, trifloxystrobin, picoxystrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, fluopicolide, benzovinflumazole, isoflurane, fluopicolide, chlorpyrifos, pyraclostrobin, methotrexate, N-( 2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide and [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate (preferably, wherein the weight ratio of component (A) to component (B) is from 100:1 to 1:100).

[0120] Preferably, in this embodiment of the present invention, a synergistic fungicidal composition is provided, comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is:

[0121] (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0122] (Compound X.02), or

[0123] (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0124] (Compound X.04);

[0125] or an agronomically acceptable salt thereof;

[0126] and

[0127] Component (B) is a compound selected from the group consisting of cyproconazole, difenoconazole, prothioconazole, fenpropidin, fenpropimorph, fludioxonil, azoxystrobin, trifloxystrobin, pyraclostrobin, mancozeb, folpet, thiophanate-methyl, benzovinflumazole, fluopicolide, chlorpyrifos, pyraclostrobin, methotrexate, N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]benzamide and [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate, wherein the weight ratio of component (A) to component (B) is from 100:1 to 1:100 (preferably from 15:1 to 1:50, more preferably from 10:1 to 1:10).

[0128] As used herein, the term "fungicide" means a compound that controls, modifies or prevents the growth of fungi. The term "fungicidally effective amount" means an amount of such a compound or a combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviations from natural development, such as killing, retardation, etc., and prevention includes the formation of a barrier or other defense in or on a plant to prevent fungal infection.

[0129] The term "plant" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, leaves and fruits.

[0130] The term "plant propagation material" means all reproductive parts of a plant, for example seeds or vegetative parts such as cuttings and tubers of a plant. It includes seeds in the strict sense, as well as roots, fruits, tubers, bulbs, rhizomes and plant parts.

[0131] As used herein, the term "locus" means a place where or on which plants grow, or where seeds of cultivated plants are sown, or where seeds are to be placed in the soil. It includes soil, seeds, and seedlings, together with established vegetation.

[0132] Throughout this document, the expression "composition" represents different mixtures or combinations of components (A) and (B) (including the embodiments defined above), for example in a single "ready-to-use" form, in a combined spray mixture (which mixture consists of separate formulations of these single active ingredients) (e.g. "tank mix"), and in the combined use of these single active ingredients when applied in a sequential manner (i.e. one after a suitably short period of time, e.g. a few hours or days) of the other. For the implementation of the present invention, the order of applying components (A) and (B) is not important.

[0133] The compositions according to the invention are effective against harmful microorganisms (such as microorganisms) which cause phytopathogenic diseases, in particular against phytopathogenic fungi and bacteria.

[0134] The compositions of the present invention can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens in the classes Basidiomycetes, Ascomycetes, Oomycetes and / or Deuteromycetes, Blastocladiomycetes, Chrytidiomycetes, Glomeromycetes and / or Mucoromycetes.

[0135] The compositions effectively control a broad spectrum of plant diseases, such as foliar pathogens of ornamental, turf, vegetable, field, cereal, and fruit crops.

[0136] These pathogens can include:

[0137] Oomycetes, including Phytophthora diseases, such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora, and Phytophthora erythroseptica; Pythium diseases, such as those caused by Pythium aphanidermatum, Pythium arrhenomanes, Pythium graminearum, Pythium irregulare, and Pythium ultimum; and Peronosporales, such as Peronospora destructor, P. cabbage, P. vinifera, P. helianthus, P. cucumeris, Albugo candidum, and P. albicans. candida), rice downy mildew, and lettuce downy mildew; and others, such as those caused by Aphanomyces spirulina, Labyrinthula zosterae, Peronosclerospora sorghi, and Sclerospora graminicola;

[0138] Ascomycetes, including stripe, spot, blast or blight and / or rot diseases, such as those caused by the order Stemphylales such as Stemphylium solani, Stagonospora tainanensis, Olea europaea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii, Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis), Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Corynespora graminicola, Bipolaris cactivora, Black spot of pitaya, Pyrenophora tritici-repentis, Alternaria brassicicola, Alternaria solanum and Alternaria tomatophila; Capnodiales such as Septoria tritici, Septoria glume, Septoria septoriaglycines, Cercospora arachis arachidicola), soybean gray spot, corn gray spot, Cercosporella capsellae, wheat leaf white mold, Cercosporella herpotrichoides, peach scab, Cladosporium carpophilum, Cladosporium effusum, Passalorafulva), Cladosporium oxysporum, Dothistromaseptosporum, Isariopsis clavispora, Black leaf spot of banana, Mycosphaerella graminicola, Mycovellosiella koepkeii, Phaeoisariopsis bataticola, Pseudocercospora vitis, Triticum basalis, Leaf spot of beet, Ramularia collo-cygni; Mesomericiales such as total rot of wheat, Magnaporthe grisea, Pyricularia oryzae; Mesomericiales such as eastern wilt of hazelnut, Apiognomonia errabunda, Cytospora platani), northern stem canker of soybean, Discula destructiva, Gnomonia fructicola, bitter rot of grapes, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-juglandacearum, Tubakia dryina, Dicarpella spp., Valsa ceratosperma; and others, such as Actinothyrium graminis, Diplosporus spp., Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Papaya serrata, Blumeriella jaapii, Candida species, Capnodium ramosum), Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopezizacampestris), Elsinoe ampelina, Echinococcus nigromaculata, Epidermophyton species, grape blight, Geotrichum candidum, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans; Gloeotinia temulenta, Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, Microdochium nivale, Monilinia truncatula fructicola), Monographella albescens, Monosporascus cannonballus, Naemacyclus spp., Ophiostoma novo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri, Petriellidium spp., Pezicula spp., Phialophora gregata, Phyllacoromigena, Phymatotrichum omnivora, Physalospora abdita, Plectosporium tabacinum), Polyscytalumpus tulans, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulisporasorghi), Rhabdocline pseudotsugaae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomi, Sclerotinia sclerotiorum, Sclerotinia minor; Sclerotium spp., Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonemaphacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina bullata, Thielviopsis basicola, Trichoseptoria fructigena, Zygophialajamaicensis; powdery mildews, for example, from the Powdery mildew order, such as B. graminis, B. graminis, Sphaerotheca fuligena, Podospaera macularis, Golovinomyces cichoracearum, Leveillula taurica, Phyllactinia diffusa, Oidiopsis gossypii, Phyllactinia guttata, and Oidium arachidis; mildew, for example, caused by Botrytis cinerea, Botryotinia allii, Botryotinia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia seriata,fabae), Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Coccidioides phaeocaulis, Phyllosticta cucurbitacearum; anthracnose, for example, those caused by Glommerelales such as Colletotrichum lagenarium, Colletotrichum oleraceus, Colletotrichum graminearum, and wilt or blight, for example, those caused by Hypocreales such as Acremonium serrata, Claviceps purpurogenum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium gloeosporum, Fusarium oxysporum f. sp. cubenense, Gerlachia oleraceus, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium gloeosporum, Fusarium oxysporum f. sp. cubenense, Gerlachia oleraceus, Fusarium graminearum, and Fusarium graminearum. nivale), Gibberella fujikura, Gibberella zeae, Glechoma spp., Myrotrichum verrucosum, Nectria ramulariae, Trichoderma viride, Polythecium roseum, and Verticillium theobromae;

[0139] Basidiomycetes, including smuts such as those caused by the Ustilaginales, such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts such as those caused by stem rust fungi, such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp.Hordei), Puccinia striiformisf.sp.Secalis), Pucciniastrum coryli; or Pucciniales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidiummucronatum, Physopella ampelosidis, Tranzschelia discolor, and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus species, Exobasidium vexans, Marasmiellus inoderma, Agaricus species, Sphacelotheca reiliana), Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma dahliae, Entylomella microspora, Neovossia moliniae, and Tilletia caries;

[0140] Cladomycetes, such as Physoderma maydis;

[0141] Mucorales, such as Choanephora cucurbitarum; Mucor species; Rhizopus arrhizus;

[0142] along with diseases caused by other species and genera closely related to those listed above.

[0143] In addition to their fungicidal activity, these compositions may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Strptomyces scabies and other related species, as well as certain protozoa.

[0144] The compositions according to the invention are particularly effective against phytopathogenic fungi belonging to the following classes: Ascomycetes (e.g. Venturia, Formosporum, Powdery Fern, Corythuja, Mycosphaeria, Uncinaria); Basidiomycetes (e.g. Hemileia, Rhizoctonia, Puccinia, Puccinia, Ustilago, Tilletia); Deuteromycetes (also known as Deuteromycetes, e.g. Botrytis, Helminthosporium, Rhizoctonia, Fusarium, Septoria, Cercospora, Alternaria, Pyrospora and Pseudocercospora); Oomycetes (e.g. Phytophthora, Peronospora, Pseudocercospora, Albugo, Discoideum, Pythium, Pseudocercoideum and Monoparana).

[0145] Useful plant crops in which the compositions according to the invention can be used include perennial and annual crops, such as berry plants, for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals, for example barley, maize (corn), millet, oats, rice, rye, sorghum, triticale and wheat; fiber plants, for example cotton, flax, jute and sisal; field crops, for example sugar and fodder beets, coffee beans, hops, mustard, rapeseed (canola), sugar cane, sunflower, tea and tobacco; fruit trees, for example apples, apricots, avocados, bananas, cherries, citrus, nectarines, peaches, pears and plums; grasses, for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. gustine and zoysia grass; herbs such as basil, borage, chives, cilantro, lavender, lovage, mint, oregano, parsley, rosemary, sage, and thyme; legumes such as beans, lentils, peas, and soybeans; nuts such as almonds, cashews, groundnuts, hazelnuts, peanuts, pecans, pistachios, and walnuts; palms such as oil palms; ornamentals such as flowers, shrubs, and trees; other trees such as cocoa, coconut, olive, and rubber trees; vegetables such as asparagus, eggplant, broccoli, cabbage, carrots, cucumbers, garlic, lettuce, zucchini, melon, okra, onions, peppers, potatoes, squash, rhubarb, spinach, and tomatoes; and vines such as grapes.

[0146] Crops are to be understood as those which occur naturally, are obtained by conventional breeding methods or are obtained by genetic engineering. They include crops which contain so-called output traits, such as improved storage stability, higher nutritional value and improved flavor.

[0147] Crops are to be understood as also including those crops which have been rendered tolerant to herbicides like bromoxynil or to classes of herbicides such as ALS-, EPSPS-, GS-, HPPD- and PPO-inhibitors. Examples of crops which have been rendered tolerant to imidazolinones (e.g. imazamox) by conventional breeding methods are Summer canola. Examples of crops that have been rendered tolerant to herbicides by genetic engineering methods include, for example, glyphosate- and glufosinate-resistant corn varieties sold under the trade names Roundup and Herculex and It is commercially available.

[0148] Crops should also be understood as those crops that are or have been naturally endowed with resistance to pests. This includes plants that have been transformed using recombinant DNA technology to, for example, be able to synthesize one or more selectively acting toxins, such as are known from, for example, toxin-producing bacteria. Examples of toxins that can be expressed include delta-endotoxins, vegetative insecticidal proteins (Vips), insecticidal proteins of bacterial colonizing nematodes, and toxins produced by scorpions, arachnids, wasps and fungi.

[0149] Examples of crops that have been modified to express Bacillus thuringiensis toxins are Bt maize (Syngenta Seeds). Examples of crops that include more than one gene encoding insecticide resistance and thereby expressing more than one toxin are (Syngenta Seeds). Crops or their seed material may also be resistant to multiple types of pests (so-called stacked transgenic events when produced by genetic modification). For example, a plant may have the ability to express an insecticidal protein while being tolerant to a herbicide, such as Herculex (Dow AgroSciences, Pioneer Hi-Bred International).

[0150] Compounds of formula (I) (including any one of compounds X.01 to X.04) or fungicidal compositions according to the present invention comprising compounds of formula (I) can be used to control or prevent phytopathogenic diseases on soybean plants, especially phytopathogenic fungi (such as Psoralea pachyrhizi).

[0151] In particular, transgenic soybean plants expressing toxins, such as insecticidal proteins such as delta-endotoxins (e.g., Cry1Ac (Cry1Ac Bt protein)). Thus, this can include transgenic soybean plants comprising event MON87701 (see U.S. Pat. No. 8,049,071 and related applications and patents, and WO 2014 / 170327 A1 (see, for example, regarding Intacta RR2PRO TM

[008] ) of soybean), event MON87751 (U.S. Patent Application Publication No. 2014 / 0373191) or event DAS-81419 (U.S. Patent No. 8,632,978 and related applications and patents).

[0152] Other transgenic soybean plants may include event SYHT0H2-HPPD tolerance (U.S. Patent Application Publication No. 2014 / 0201860 and related applications and patents), event MON89788-glyphosate tolerance (U.S. Patent Application Publication No. 7,632,985 and related applications and patents), event MON87708-dicamba tolerance (U.S. Patent Application Publication No. US 2011 / 0067134 and related applications and patents), event DP-356043-5-glyphosate and ALS tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-12-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-13-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-20-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-21-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-22-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-23-glufosinate tolerance (U.S. Patent Application Publication No. US2010 / 0184079 and related applications and patents), event A2704-21-glufosinate tolerance (U.S. Patent Application Publication No. US2010 2008 / 0320616 and related applications and patents), event DP-305423-1-ALS tolerance (U.S. Patent Application Publication No. US2008 / 0312082 and related applications and patents), event A5547-127-glufosinate tolerance (U.S. Patent Application Publication No. US 2008 / 0196127 and related applications and patents), event DAS-40278-9-tolerance to 2,4-dichlorophenoxyacetic acid and aryloxyphenoxypropionate (see WO 2011 / 022469, WO 2011 / 022470, WO 2011 / 022471, and related applications and patents), event 127-ALS tolerance (WO 2010 / 080829 and related applications and patents), event GTS 40-3-2 - glyphosate tolerance, event DAS-68416-4-2,4-dichlorophenoxyacetic acid and glufosinate tolerance, event FG72 - glyphosate and isoxathiapiprolin tolerance, event BPS-CV127-9 - ALS tolerance, and GU262 - glufosinate tolerance or event SYHT04R - HPPD tolerance.

[0153] Compounds of formula (I) (including any one of compounds X.01 to X.04) or fungicidal compositions according to the invention comprising compounds of formula (I) can be used to control or prevent phytopathogenic diseases on soybean plants, especially phytopathogenic fungi (such as pachyrhizium spp.). In particular, certain superior soybean plant varieties are known in the scientific literature in which R gene stacks conferring a certain degree of immunity or resistance to specific pachyrhizium spp. have been infiltrated into the plant genome, see, for example: "Fighting Asian Soybean Rust", Langenbach C et al., Front Plant Science 7 (797) 2016).

[0154] A superior plant is any plant from a superior line, and thus a superior plant is a representative plant from a superior variety. Non-limiting examples of superior soybean varieties commercially available to farmers or soybean breeders include: AG00802, A0868, AG0902, A1923, AG2403, A2824, A3704, A4324, A5404, AG5903, AG6202, AG0934; AG1435; AG2031; AG2035; AG2433; AG2733; AG2933; AG3334; AG3832; AG4135; AG4632; AG4934; AG5831; AG6534; and AG7231 (Asgrow Seeds, Des Moines, Iowa, USA); BPR 0144RR, BPR 4077NRR and BPR 4390NRR (Bio Plant Research, Camp Point, IL, USA); DKB17-51 and DKB37-51 (DeKalb Genetics, DeKalb, IL, USA); DP 4546RR, and DP 7870RR (Delta & Pine Land Company, Lubbock, TX, USA); JG03R501, JG 32R606C ADD, and JG 55R503C (JGL Inc.), Greencastle, Indiana, USA); NKS13-K2 (NK Division of Syngenta Seeds, Golden Valley, Minnesota, USA); 90M01, 91M30, 92M33, 93M11, 94M30, 95M30, 97B52, P008T22R2; P16T17R2; P22T69R; P25T51R; P34T07R2; P35T58R; P39T67R; P47T36R; P46T21R; and P56T03R2 (Pioneer Hi-Bred International, Inc. Hi-Bred International, Johnston, IA, USA); SG4771NRR and SG5161NRR / STS (Soygenetics, LLC, Lafayette, IN, USA); S00-K5, S11-L2, S28-Y2, S43-B1, S53-A1, S76-L9, S78-G6, S0009-M2; S00 7-Y4; S04-D3; S14-A6; S20-T6; S21-M7; S26-P3; S28-N6; S30-V6; S35-C3; S36-Y6; S39-C4; S47-K5; S48-D9; S52-Y2; S58-Z4; S67-R6; S73-S8; and S78-G6 (Syngenta Seeds, Henderson, KY, USA); Richer (Northstar Seed Ltd., Alberta, Canada); 14RD62 (Stine Seed Co., Iowa, USA); or Armor 4744 (Armor Seed, LLC, Alaska, USA).

[0155] Therefore, in another preferred embodiment, a fungicidal composition according to the present invention comprising a compound having formula (I) (including any one of compounds X.01 to X.04) is used to control Psora pachyrhizi (including fungicidal resistant strains thereof, as described below) on elite soybean plant varieties, wherein a stack of R genes conferring a certain degree of immunity or resistance to a particular Psora pachyrhizi has been introgressed in the plant genome. From such use, many benefits can be expected, such as improved biological activity, favorable or broader activity spectrum (including sensitive and resistant strains of Psora pachyrhizi), increased safety, improved crop tolerance, synergistic interactions or enhanced properties, improved onset or longer lasting residual activity, reduction in the number of applications of compounds and compositions required to effectively control plant pathogens (Psora pachyrhizi), and / or reduction in their application rates, thereby achieving beneficial resistance-management practices, reduced environmental impact and reduced operator exposure.

[0156] In certain cases, the fungicidal composition according to the present invention comprising a compound of formula (I) may show synergistic interactions between the active ingredients when used to control or prevent phytopathogenic diseases, especially phytopathogenic fungi (such as Psoralea pachyrhizi) on soybean plants (especially any transgenic soybean plants as described above).

[0157] The fungicidal composition according to the invention comprising a compound of formula (I) (including any one of compounds X.01 to X.04) can be used to control or prevent phytopathogenic diseases, especially phytopathogenic fungi (particularly Phakopsora pachyrhizi) on soybean plants.

[0158] Additionally, to date, no cross-resistance has been observed between the fungicidal composition according to the present invention comprising a compound having formula (I), including any of compounds X.01 to X.04, and current fungicidal solutions for controlling Phakopsora pachyrhizi.

[0159] Indeed, fungicidal resistant strains of Phakopsora pachyrhizi have been reported in the scientific literature, where strains resistant to one or more fungicides from at least each of the following fungicidal mode of action categories: sterol demethylation inhibitors (DMIs), quinone outside inhibitors (QoIs) and succinate dehydrogenase inhibitors (SDHIs) have been observed. See, for example: "Sensitivity of Phakopsora pachyrhizi towards quinone-outside-inhibitors and demethylation-inhibitors, and corresponding resistance mechanisms." Schmitz HK et al., Pest Manag Sci (2014) 70: 378-388; "First detection of a SDH variant with reduced SDHI sensitivity in Phakopsora pachyrhizi" K et al., J Plant Dis Prot (2018) 125:21-2; “Competitive fitness of Phakopsora pachyrhizi isolates with mutations in the CYP51 and CYTB genes.” Klosowski AC et al., Phytopathology (2016) 106:1278-1284; “Detection of the F129L mutation in the cytochrome b gene in Phakopsora pachyrhizi.” Klosowski AC et al., Pest Management Sci (2016) 72:1211-1215.

[0160] Therefore, in a preferred embodiment, the fungicidal composition according to the present invention comprising a compound of formula (I) (including any one of compounds X.01 to X.04) is used to control Phakopsora pachyrhizi, which is resistant to one or more fungicides from any one of the following fungicidal MoA classes: sterol demethylation inhibitors (DMI), quinone external inhibitors (QoI) and succinate dehydrogenase inhibitors (SDHI).

[0161] The compounds constituting component A of the present invention can be prepared as shown in the following scheme, wherein R 1 , R 2 , R 3 and R 4 As defined for formula (I).

[0162] A compound having formula (I) (wherein R 1 , R 2 , R 3 and R 4 As defined above) can be prepared by reacting a compound of formula (II) wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 11 is a halide or pseudohalide such as chlorine, bromine, iodine, -OSO2CF3 or -OSO2(CF2)3CF3) and a compound having formula (III) (wherein R 4As defined for compounds of formula (I), and M is a metalloid or pseudo-metalloid species (e.g., M includes, but is not limited to, MgCl, ZnCl, or B(OH)2)). For related examples, see: Journal of Organic Chemistry, 2010, 75, 6677-6680, Journal of the American Chemical Society, 2009, 131, 7532-7533, European Journal of Medicinal Chemistry, 2018, 147, 238-252, and "Cross-Coupling Reactions: A Practical Guide (Topics in Current Chemistry)" edited by Norio Miyaura and S.L. Buchwald (Springer edition), or by Armin de Meijere and Diederich, ed., Metal-Catalyzed Cross-Coupling Reactions (WILEY-VCH ed.).

[0163] This is shown in Scheme 1.

[0164]

[0165] Solution 1

[0166] Alternatively, the compound of formula (I) may be prepared by reacting a compound of formula (IV) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I), and R 12(a partially unsaturated, optionally substituted C3-C7 cycloalkenyl) is obtained by reaction via a reduction method (e.g., hydrogenation using a hydrogen source in the presence of a catalyst complex such as palladium on carbon in an organic solvent such as methanol, tetrahydrofuran or ethyl acetate at a temperature between 0°C and 150°C). For relevant examples, see: ACS Medicinal Chemistry Letters, 2016, 7, 508-51. Shigeo Nishimura's 'Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis' (published by Wiley-VCH) or Johannes de Vries and Cornelis Elsevier's 'The Handbook of Homogeneous Hydrogenation' (published by Wiley-VCH). This is shown in Scheme 2.

[0167]

[0168] Solution 2

[0169] A compound having formula (IV) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I), and R 12 is a partially saturated and optionally substituted C3-C7 cycloalkenyl) can be reacted via a compound of formula (II) (wherein R 11It is obtained by a cross-coupling reaction between a halide or pseudo-halide such as chlorine, bromine, iodine, -OSO2CF3 or -OSO2(CF2)3CF3) and a compound of formula (V) (wherein M represents a metalloid or pseudo-metalloid substance (e.g., M includes but is not limited to B(OH)2, BPin, SnBu3) or hydrogen). For relevant examples, see: ACS Medicinal Chemistry Letters, 2016, 7, 508-513 and "Cross-Coupling Reactions: A Practical Guide (Topics in Current Chemistry)" edited by Norio Miyaura and SL Buchwald (Springer Edition), or by Armin de Meijere and Diederich, ed., "Metal-Catalyzed Cross-Coupling Reactions" (WILEY-VCH ed.). This is shown in Scheme 3.

[0170]

[0171] Solution 3

[0172] A compound having formula (II) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 11 is a halide or pseudohalide such as chlorine, bromine, iodine, -OSO2CF3 or -OSO2(CF2)3CF3) can be prepared from a compound having formula (VI) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I), R 11 As defined above and R 13 is H or C1-C4 alkyl) is obtained by treating with a suitable base such as sodium methoxide and a formylation agent such as methyl formate, optionally in a suitable solvent such as tetrahydrofuran, to produce a compound of formula (VIa) wherein R 1 , R 2 and R 3 As defined for compounds of formula (I), R 11 As defined above and R 14is H or methyl), followed by methylation with a reagent such as dimethyl sulfate, optionally in the presence of a base such as K2CO3. For related examples, see: Journal of Agricultural and Food Chemistry, 2007, 55, 5697-5700, Molecules, 2010, 15, 9024-9034 and Organic Process Research and Development, 2015, 19, 639-645. This is shown in Scheme 4.

[0173]

[0174] Solution 4

[0175] A compound having formula (VI) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I), R 11 As defined above and R 13 is H or C1-C4 alkyl) can be obtained by a compound having formula (VII) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 11 As defined above) by reacting a base such as K2CO3 and an alkylating agent of formula (VIII) (wherein R 13 is H or C1-C4 alkyl). Compounds of formula (VII) are commercially available or readily prepared from commercially available compounds by standard functional group transformations as described in March's Advanced Organic Chemistry, Smith and March, 6th edition, Wiley, 2007. This is shown in Scheme 5.

[0176]

[0177] Solution 5

[0178] A compound having formula (I) (wherein R 1 , R 2 , R 3 and R 4 As defined for compounds of formula (I)) can also be prepared from compounds of formula (IX) wherein R 1 , R 2 , R3 and R 4 As defined for compounds of formula (I) and R 13 is H or C1-C4 alkyl) is obtained by treating with a base such as sodium methoxide and a formylation agent such as methyl formate to generate a compound of formula (X) (wherein R 1 , R 2 , R 3 and R 4 As defined for compounds of formula (I) and R 14 is H or methyl), followed by methylation with a reagent such as dimethyl sulfate in the presence of a base such as K2CO3. For related examples, see: Journal of Agricultural and Food Chemistry, 2007, 55, 5697-5700, Molecules, 2010, 15, 9024-9034 and Organic Process Research and Development, 2015, 19, 639-645. This is shown in Scheme 6.

[0179]

[0180] Solution 6

[0181] A compound having formula (IX) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 4 is an optionally substituted cyclopropyl) can be prepared from a compound having the formula (XI) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 15 represents an optionally substituted alkenyl) by treating with diiodomethane with an organozinc reagent such as diethylzinc, optionally in the presence of an acid source such as trifluoroacetic acid, and in an organic solvent such as dichloromethane. For related examples, see: Organic Reactions, 2001, 58, 1.

[0182] This is shown in Scheme 7.

[0183]

[0184] Solution 7

[0185] A compound having the formula (XI) (wherein R 1 , R 2 and R3 As defined for compounds of formula (I), R 15 As defined above and R 13 is H or C1-C4 alkyl) can be obtained by a compound having formula (XII) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 15 As defined above) by reacting a base such as K2CO3 and an alkylating agent of formula (VIII) (wherein R 13 is H or C1-C4 alkyl). This is shown in Scheme 8. For related examples, see: European Journal of Organic Chemistry, 2015, 2197-2204. Compounds of formula (VIII) are commercially available or readily prepared from commercially available compounds by standard functional group transformations as described in March's Advanced Organic Chemistry, Smith and March, 6th edition, Wiley, 2007.

[0186]

[0187] Solution 8

[0188] A compound having the formula (XII) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 15 As defined above) can be reacted via a compound of formula (VII) (wherein R 1 , R 2 and R 3 As defined for compounds of formula (I) and R 11 is a halide or pseudohalide such as chlorine, bromine, iodine, -OSO2CF3 or -OSO2(CF2)3CF3) and a compound having formula (XIII) (wherein R 15As defined above and M represents a metalloid or pseudo-metalloid (e.g., M includes but is not limited to B(OH)2, BPin, SnBu3) or hydrogen) coupling transformation preparation. For related examples, see: Journal of Medicinal Chemistry [Journal of Medicinal Chemistry], 2015, 58, 9258-9272 and Journal of Medicinal Chemistry [Journal of Medicinal Chemistry], 2014, 57, 1252-1275. This is shown in Scheme 9.

[0189]

[0190] Solution 9

[0191] Functional group interconversions described in the previous schemes are known to those skilled in the art. An extensive list of reaction conditions can be found in: Comprehensive Organic Functional Group Transformations, edited by AR Katritzky, O. Meth-Cohn and C W Rees., Pergamon Press (Elsevier Science Ltd.), Tarrytown, NY 1995; or Comprehensive Organic Transformations: A Guide to Functional Group Preparations, edited by Richard C. Larock, Wiley-VCH, New York 1999.

[0192] If the synthesis results in a mixture of isomers, separation is generally not necessarily necessary, since the individual isomers may in some cases be converted into one another during post-processing for use or during application (e.g. under the action of light, acids or bases). Such conversions may also take place after use, for example in the treated plants, in plant treatment or in the harmful fungi to be controlled.

[0193] The compositions of the present invention, including all of the above disclosed embodiments and preferred examples thereof, may be mixed with one or more additional pesticides, including additional fungicides, insecticides, nematicides, bactericides, acaricides, growth regulators, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants or other biologically active compounds to form multi-component pesticides giving a broader spectrum of agricultural protection.

[0194] Examples of such agricultural protectants and compositions of the present invention may be formulated as:

[0195] Fungicides such as thiabendazim, fluazinam, bensulfuron, bensulfuron-M (bensulfuron-M), furalaxyl, metalaxyl, metalaxyl-M (metalaxyl-M), dodecin, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, ethidium, 3'-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]acetyl-2',6'-dimethoxy Methylaniline (clozylacon), cyprodinil, myclobutanil, myclobutanil, dithianon, aureomycin, blasticidin-S, biphenyl, chloranil, benzovinflumizole, fluopicolide, hexachlorobenzene, pentachloronitrobenzene, tetrachloronitrobenzene (TCNB), methyl tolclofos, mefenamic acid, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopicolide or flupicolide, tioxymid, sulfaquinoxaline, benomyl, carbendazim, carbendazim hydrochloride, chlorfenazole, thiabendazole, methyl thiophanate, benzthiopyrad, thiopyrad, thiabendazole, a bethoxazin, pyriofenone (IKF-309), acibenzolar-S-methyl, pyrimidine (KIF-7767), butylamine, 3-iodo-2-propynyl n-butylcarbamate (IPBC), iodopropynyl butylcarbamate (iodocarb) (isopropyl butylcarbamate), isopropyl butylcarbamate (iodopropynyl butylcarbamate), tetrazolylpyrrolidone, polycarbamate, propamocarb, tolprocarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, dichlorocyanurate oxadiazole, N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methyl-pyrazole-4-carboxamide, cyclopropane, thiophanate-methyl, flumorph, oxine-copper, cymoxanil, cyproconazole, cyazolin, fluthiazolin, thiophanate-methyl, thiophanate-butyl, thiophanate-methyl, thiophanate-butyl, thiophanate-methyl, thiophanate-butyl, thiophanate-methyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl, thiophanate-butyl5,7(2H,6H)-tetraketone, thiram oxide, mancozeb, ferram, mancozeb, maneb, metam, metiram or polyram, metiram-zinc, mancozeb, methyl propineb, thiram, vapam or metam sodium), mancozeb, ziram, dimethyl disulfide, pyralid, fosetyl, fosetyl-Aluminum, methyl bromide, methyl iodide, methyl isothiocyanate, cyclamic acid, methyl furamide, validamycin, streptomycin, (2RS)-2-bromo-2-(bromomethyl)glutaronitrile (bromocycline), doguadine, iminoctadine, iminoctadine triacetate, 2,4-D, 2,4-DB, kasugamycin, mefenamic acid, cyclamic acid, oxazolidinone, imazalil, imazalil sulfate sulphate), oximidazole, rice blast ester, prochloraz, trifloxystrobin, imidacloprid, Bordeaux mixture, calcium polysulfide, copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper hydroxyquinoline, copper silicate, copper sulfate, copper tallate, cuprous oxide, sulfur, carbaryl, rice blast phthalide (tetrachlorophthalide), pyraclostrobin (dingjunezuo) (Jun Siqi) (Jun Si Qi), oxathiapiprolin, fluoroimide, dimethomorph, KSF-1002, benzamorf, oxathiapiprolin, fenmorph, tridemorph, dodecamorph, ethotripsy, triphenyltin acetate, triphenyltin hydroxide, carboxin, carboxin oxide, dithiocarb, oxathiapiprolin, m-phenylphenol, p-phenylphenol, tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl )oxy]-6-fluoro-phenyl]propane-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propane-2-ol, cyfluthrin, furamide, oxadone, flutolanil, oxadiazine, isofetamid, fenpyroxil, flutolanil, isofetamid, fludioxonil, pencuronium, chlorpyrifos, isofetamine, chloranil, phosphoric acid, chloranil, captan, captan, chloranil, chloranil, chloranil, chloranil, 1-methylcyclopropene, 4-CPA, chlormequat, chloranil, 2-methylcyclopropene, 1-methylcyclopropene, 4-CPA, chlormequat, chloranil, 2-methylcyclopropene, 2-methylcyclopropene, 1 ...4-Dichloropropionic acid, thiamethoxam, endoxan, ethephon, flumetralin, chlorfenapyr, gibberellic acid, gibberellin, oxadiazine, maleic hydrazide, mepiquat, naphthacetamide, paclobutrazol, prohexadione, prohexadione calcium, thidiazuron, tributyl trithiophosphate, anti-invertase, uniconazole, α-naphthylacetic acid, polyoxin D (polyoxrim), BLAD, chitosan, cyanamide, folpet, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bixafen, flupyrad, furazolidone, pyraclostrobin, pentofenpyrad, penthiopyrad, fluazole, oxadiazine, pyraclostrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin Canthoxime, boscalid, fluopyram, difluprednisolone, chlorpyrifos, 5-fluoro-2-(p-tolylmethoxy)pyrimidine-4-amine, pyrimidine, dimetachlone or dimethaclone, pyroquilone, propoxyquin, ethoxyquin, quinoxyfen, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazine, isobutylethoxyquinoline, oxolinic acid (oxolinic acid acid), chinomethionate or oxythioquinox, quinoxymethionate, spiroxabiocin, (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide, (Mandesbin), azoxystrobin, syringosterone, ethersstrobin, enestroburin, enoxastrobin, fenamistrobin, flutoxin, fluoxastrobin, ethersstrobin, Mandesbin, fenoxystrobin, formic acid, oxadiazine, picoxystrobin, pyraclostrobin, pyraclostrobin, pyraclostrobin, chlorpyrifos, oxadiazine, indazolesulfonamide, antibacterial , tolylfluanid, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamate, dazomethon, isothiopyrad, thiopyrad, thiofuran, benzthiocyanate (TCMTB), thiopyrad, oxazolidinone, antifungal, tricyclazole, (.+-.)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (huanjunzuo), 1-(5-bromo-2-pyridinyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propan-2-ol, 2-(1-tert-butyl)-1-(2-chlorophenyl)-3-(1,2,4-Triazol-1-yl)-propan-2-ol (TCDP), azaconazole, bifenthrinol (bifenthrinol), bramconazole, climbazole, cyproconazole, difenoconazole, dimetconazole, diniconazole, diniconazole-M, fluquinconazole, ethoconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imidoazole, ipfentrifluconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, silyconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, imidazolin, trichlorfonazole, clofoconazole, 2-[[(1R,5S)-5-[(4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl]-4H-1,2,4-triazole-3-thione, ametoctradin or imidium, isopropanil, valeramide, 2-benzyl-4-chlorophenol (benzyl chlorophenol), allyl alcohol, oxazolidinone, benzalkonium chloride, chloropicrin, cresol, daracide, dichlorophen (dichlorophenol), avenanthrone, pyridinium dithiocarbamate, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, NNF-0721, octhiocarbazone, oxazolidinone, propaneamidine and propionic acid.

[0196] Insecticides such as avermectin, acetamiprid, sulfamethoxam (S-1955), avermectin, azadirachtin, methyl azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, chlorfenapyr (DPX-E2Y45), chlorfenapyr, chlorpyrifos, methyl chlorpyrifos, chromafenazol, clothianidin, cyfluthrin, β-cyfluthrin, cyhalothrin , λ-cyhalothrin, cypermethrin, cyromazine, deltamethrin, butafenamide, diazinon, dieldrin, diflubenzuron, tetrafluthrin, dimethoate, dinotefuran, benzylpezil, emamectin, endosulfan, cypermethrin, ethiprole, fenthiocarb, fenoxycarb, cypermethrin, cypermethrin, fipronil, flonicamid, flubendiamide, flucythrinate, τ-fluvalinate, cypermethrin, flufenoxam (UR-50701), flufenoxuron, flufenoxam, chlorfenapyr , hexaflumuron, hydrazone, imidacloprid, indoxacarb, isoflurane, fenthion, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methoprene, methoxychlor, methoxyfluthrin, monocrotophos, methoxyfenozide, nitenpyram, nitrothiazole, bisbenzenecarb, polyflumuron (XDE-007), oxamyl, parathion, methyl parathion, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profenofos Pyrethroids, pymetrozine, pyraclostrobin, pyrethrins, pyridalyl, flubendiamide, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN2060), spirotetramat, thioprofos, tebufenozide, tetrafluthrin, terbufos, tetramethoate, thiodicarb, thiomethopid, tralomethrin, triazolam, trichlorfon and trimethomorph;

[0197] bactericides such as streptomycin;

[0198] Acaricides such as amitraz, chlorpyrifos, chlorfenapyr, cypermethrin, cypermethrin, fenbutol, cypermethrin, fenazaquin, fenbutol, cypermethrin, fenpyraclostrobin, hexythiazox, propargite, pyridaben and cypermethrin; and

[0199] Biological agents such as Bacillus thuringiensis, Bacillus thuringiensis delta endotoxin, baculovirus and insect pathogenic bacteria, viruses and fungi.

[0200] Other examples of "reference" mixture compositions are as follows (wherein the term "TX" denotes a compound selected from compound number X.01, X.02, X.03 or X.04 as defined in Table X above (definition of component (A) of the composition of the invention): a compound selected from the group consisting of petroleum + TX, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol + TX, 2,4-dichlorophenylbenzenesulfonate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 4-chlorophenylphenyl sulfone + TX, acetothion + TX, aldicarb + TX, sirox + TX, fomanphos + TX, fenthion + TX, oxalophos + TX, amitraz + TX, arsenic trioxide + TX, azobenzene + TX, azophos + TX, benomyl + TX, benoxafos + TX, benzyl benzoate + TX, bixafen + TX, bromethrin + TX, broflanilide + TX, bromophenoxate + TX, bromothiocarb + TX, bromopyralid + TX, bromopyralid + TX, buprofezin + TX, butanone + TX, butanone sulfone + TX, butylpyridaben + TX, calcium polysulfide + TX, octachlorocamphene + TX, chlormethoxam + TX, trithion + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin hydrochloride + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin + TX, cypermethrin + TX, ethyl cypermethrin + TX, cypermethrin ( chloromebuform)+TX, diflubenzuron+TX, propyl cypermethrin+TX, cypermethrin+TX, cypermethrin I+TX, cypermethrin II+TX, cypermethrin+TX, closantel+TX, coumaphos+TX, crotamiton+TX, baclofos+TX, thiocarb+TX, fruit insect phosphorus+TX, DCPM+TX, DDT+TX, tianlephos+TX, tianlephos-O+TX, tianlephos-S+TX, demeton-methyl+TX, demeton-O+TX, demeton-O-methyl+TX, demeton-S+TX, demeton-S-methyl+TX, demeton-S-methyl+TX, demeton-S-methyl+TX, demeton-S-methyl+TX, demeton-S-methylsulfon+TX, bacteriostatic+TX, dichlorvos+TX, dichlorvos (dicliphos) + TX, dichlorvos + TX, methylphos + TX, dinex + TX, dinex-diclexine + TX, dinocap-4 + TX, dinocap-6 + TX, orthodiphos + TX, nitropentyl + TX, nitrooctyl acaricide + TX, nitrobutyl + TX, dithiophos + TX, sulfodiphenyl + TX, disulfiram + TX, DNOC + TX, dofenapyn + TX, doramectin + TX, indophos + TX, eprinomectin + TX, thiophos + TX, ethiprox + TX, anti-mite azole + TX, fenbutatin + TX, fenthiocarb + TX, fenpyrad + TX, fenpyrad + TX,Amifenpyrazone + TX, mitrac + TX, fentrifanil + TX, fluazifop + TX, fluazifop + TX, fluazifop + TX, fluazifop + TX, FMC1137 + TX, fluazifop + TX, fluazifop hydrochloride + TX, formparanate + TX, γ-HCH + TX, fruit green + TX, benzyl acarboxylate + TX, hexadecyl cyclopropane carboxylate + TX, isocarbophos + TX, jasmonate I + TX, jasmonate II + TX, iodine + TX, lindane + TX, propanil + TX, cypermethrin + TX, dithiophos + TX, methylthiophene + TX, cypermethrin + TX, methyl bromide + TX, cypermethrin + TX, chlorpyrifos + TX, mil Bezoar + TX, propylamine fluorine + TX, monocrotophos + TX, maoguo + TX, moxidectin + TX, naled + TX, 4-chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, fluazifop + TX, nikkomycin + TX, pentocyanamide + TX, pentocyanamide 1:1 zinc chloride complex + TX, omethoate + TX, isothiocarb + TX, sulfone + TX, pp'-DDT + TX, parathion + TX, permethrin + TX, fenthion + TX, phosalone + TX, thiocyclic phosphorus + TX, phosphamidon + TX, polychloroterpenes + TX, acaricide (polynact ins)+TX, propylchloranol+TX, cypermethrin+TX, propoxur+TX, ethidium+TX, pyrethrin+TX, pyrethrin I+TX, pyrethrin II+TX, pyrethrin+TX, pyrimethoxam+TX, pyrimithin+TX, quinalphos+TX, quintiofos+TX, R-1492+TX, glyphosate+TX, rotenone+TX, octamidine+TX, clomiphene+TX, selamectin+TX, thiophos+TX, SSI-121+TX, sulfilam+TX, sulfluramid+TX, sulfotep+TX, sulfur+TX, fluazifop+TX, τ-fluvalinate+TX, TEPP+TX, terbutaline+TX, tetrachlorobenzene Acaricide sulfone + TX, acaricide good + TX, thiafenox + TX, anti-insecticidal carbendazim + TX, long-acting carbendazim + TX, methyl thiophos + TX, chlorpyrifos + TX, thiamethoxam + TX, triazophos + TX, triazuron + TX, trichloropropoxyphos + TX, triamcin + TX, aphidicide + TX, vaniliprole + TX, bethoxazin + TX, copper dioctanoate + TX, copper sulfate + TX, 2-tert-butylamino-4-cyclopropylamino-6-methylthio-s-triazine (cybutryne) + TX, dichloronaphthoquinone + TX, dichlorophen + TX, endoxan + TX,Triphenyltin + TX, slaked lime + TX, sodium mancozeb + TX, algaecide + TX, quinone + TX, simazine + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, fusulin + TX, piperazine + TX, thiophanate + TX, chloralose + TX, fenthion + TX, pyridine-4-amine + TX, strychnine + TX, 1-hydroxy-1H-pyridine-2-thione + TX, 4-(quinoxaline-2-ylamino)benzenesulfonamide + TX, 8-hydroxyquinoline sulfate + TX, bronopol + TX, copper hydroxide + TX, cresol + TX, dipyrithione +TX, dodixin +TX, sodium sulfone +TX, formaldehyde +TX, mercury plus phen +TX, kasugamycin +TX, kasugamycin hydrochloride hydrate +TX, nickel di(dimethyldithiocarbamate) +TX, trichloromethylpyridine +TX, octhiothione +TX, oxolinic acid +TX, oxytetracycline +TX, potassium hydroxyquinoline sulfate +TX, thiabendazole +TX, streptomycin +TX, streptomycin sesquisulfate +TX, chloranthracene +TX, thimerosal +TX, cotton brown banded moth GV +TX, radiobacterium +TX, Amblyseius species ( spp.)+TX, celery armyworm NPV+TX, Anagrus atomus+TX, Aphelinus abdominalis+TX, Aphidius colemani+TX, Aphidoletes aphidimyza+TX, Spodoptera exigua NPV+TX, Bacillus sphaericus Neide+TX, Beauveria brongniartii+TX, Chrysoperla carnea+TX, Cryptolaemus montrouzieri+TX, Codling moth GV+TX, Dacnusa sibirica+TX, Diglyphus isaea+TX, Encarsia spp. formosa)+TX, Eretmocerus eremicus+TX, Heterorhabditis bacteriophora and H.megidis+TX, Hippodamia convergens+TX, Leptomastix dactylopii+TX, Macrolophus caliginosus+TX, Cabbage armyworm NPV+TX, Metaphycus helvolus+TX,Metarhizium anisopliae var. acridum+TX, Metarhizium anisopliae var. anisopliae+TX, Neodiprion sertifer NPV and N. lecontei NPV+TX, species of the genus Pseudomonas+TX, Paecilomyces fumosoroseus+TX, Phytoseiulus persimilis+TX, Steinernema bibionis+TX, Steinernema carpocapsae+TX, Steinernema glaseri+TX, Steinernema riobrave+TX、Steinernema riobravis+TX、Steinernema capterisci+TX、Steinernema spp.+TX、Trichogramma species+TX、Typhlodromus occidentalis+TX、Verticillium lecanii+TX、apholate+TX、bisazir+TX、busulfan+TX、dimatif+TX、hemel+TX、hempa+TX、metepa+TX、methiotepa+TX、methyl apholate+TX、bis(aziridine)methylaminophosphine sulfide+TX、 apholate) + TX, morzid + TX, penfluron + TX, tepa + TX, thiohempa + TX, thiohempa + TX, trothamide + TX, urethaneimide + TX, (E)-dec-5-en-1-yl acetate and (E)-dec-5-en-1-ol + TX, (E)-tridec-4-en-1-yl acetate + TX, (E)-6-methylhept-2-en-4-ol + TX, (E,Z)-tetradec-4,10-dien-1-yl acetate + TX, (Z)-dodec-7-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)-hexadec-11-en-1-yl acetate + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX,(Z)-eicos-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)-tetradec-9-en-1-yl acetate + TX, (7E,9Z)-dodec-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradec-9,11-dien-1-yl acetate + TX, (9Z,12E)-tetradec-9,12-dien-1-yl acetate Acetate + TX, 14-methyloctadec-1-ene + TX, 4-methylnon-5-ol and 4-methylnon-5-one + TX, α-polystyrene + TX, western pine beetle aggregation pheromone + TX, codlelure + TX, codlemone + TX, cuelure + TX, epoxide nonadecane + TX, dodec-8-en-1-yl acetate + TX, dodec-9-en-1-yl acetate +TX, dodecane-8+TX, 10-diene-1-yl acetate+TX, dominicalure+TX, 4-methyloctanoic acid ethyl ester+TX, eugenol+TX, frontalin+TX, grandlure+TX, grandlure I+TX, grandlure II+TX, grandlure III+TX, grandlure IV+TX, hexalure+TX, ipsdienol+TX, ipsenol+TX, japonilure+TX, lineatin+TX, litlure+TX, looplure+TX, medlure+TX, megatomoic acid acid)+TX, methyl eugenol+TX, muscalure+TX, octadecane-2,13-diene-1-yl acetate+TX, octadecane-3,13-diene-1-yl acetate+TX, orfralure+TX, oryctalure+TX, ostramone+TX, siglure+TX, sordidin+TX, sulcatol+TX, tetradecane-11-ene-1-yl acetate+TX, trimedlure+TX, Mediterranean fruit fly attractant A+TX, Mediterranean fruit fly attractant B1+TX, Mediterranean fruit fly attractant B2+TX, Mediterranean fruit fly attractant C+TX, trunc-call+TX, 2-(octylthio)ethanol+TX,Butopyronoxyl + TX, butoxy (polypropylene glycol) + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, DEET + TX, dimethyl carbate + TX, dimethyl phthalate + TX, ethyl hexanediol + TX, hexamide + TX, methoquin-butyl + TX, methylneodecanamide + TX, oxamate + TX, picaridin + TX, 1-dichloro-1-nitroethane + TX, 1,1-dichloro-2,2-di(4-ethylphenyl)-ethane + TX, 1,2-dichloropropane and 1,3-dichloropropylene + TX, 1-bromo-2-chloroethane + TX, 2,2,2-trichloro-1- (3,4-Dichloro-phenyl)ethyl acetate + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate + TX, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate + TX, 2-(2-butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-chlorovinyl diethyl phosphate + TX, 2-imidazolidinone + TX, 2-isovaleryl indan-1,3-dione + TX, 2-methyl (prop-2-ynyl) aminophenyl methylcarbamate +TX, 2-thiocyanatoethyl laurate +TX, 3-bromo-1-chloroprop-1-ene +TX, 3-methyl-1-phenylpyrazol-5-yl dimethyl-carbamate +TX, 4-methyl (prop-2-ynyl) amino-3,5-xylyl methylcarbamate +TX, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate +TX, athidathion +TX, acrylonitrile +TX, aldrin +TX, alloamicin +TX, cypermethrin +TX, α-decimin +TX, aluminum phosphide +TX, cypermethrin +TX, neonicotinoid +TX, ethylthiophos (athidathion) +TX, methylpyrifos +TX, threonine Bacillus yunjinensis δ-endotoxin + TX, barium hexafluorosilicate + TX, barium polysulfide + TX, fumonisin + TX, Bayer 22 / 190 + TX, Bayer 22408 + TX, β-cyfluthrin + TX, β-cypermethrin + TX, bioethanomethrin + TX, biopermethrin + TX, bis (2-chloroethyl) ether + TX, borax + TX, bromophenoxyacetic acid + TX, bromo-DDT + TX, synchlorpyrifos + TX, cypermethrin + TX, butathiofos + TX, butyl ester + TX, calcium arsenate + TX, calcium cyanide + TX, carbon disulfide + TX, carbon tetrachloride + TX,Badan hydrochloride + TX, cevadine + TX, borneol + TX, chlordane + TX, chlordecone + TX, chloroform + TX, chloropicrin + TX, chlornitroxime + TX, chlorprazophos + TX, cis-resmethrin + TX, cismethrin + TX, clocythrin (alias) + TX, copper acetoarsenite + TX, copper arsenate + TX, copper oleate + TX, coumithoate + TX, cryolite + TX, CS 708+TX, benzonitrile+TX, cypermethrin+TX, cypermethrin+TX, cypermethrin+TX, d-cypermethrin+TX, DAEP+TX, dazomethane+TX, decarbofuran+TX, diamidafos+TX, isochlorphos+TX, dimethophos+TX, dicresyl+TX, cypermethrin+TX, dieldrin+TX, diethyl 5-methylpyrazol-3-yl phosphate+TX, dior+TX, tetrafluthrin+TX, demicarb+TX, pyrethrin+TX, methylchlorfenapyr+TX, difenocarb+TX, propanol+TX, pentotropol+TX, dinoseb+TX, fenpyroxene+TX, vegetable phosphorus+TX, thiopyrafos+TX, DSP+TX, ecdysterone+TX, EI 1642+TX, EMPC+TX, EPBP+TX, etaphos+TX, ethiobencarb+TX, ethyl formate+TX, ethylene dibromide+TX, ethylene dichloride+TX, ethylene oxide+TX, EXD+TX, pyrifos+TX, ethiobencarb+TX, fenitrothion+TX, fenoxacrim+TX, cypermethrin+TX, fenthion+TX, ethylfenthion+TX, flucofuron+TX, butylfenthion+TX, phosphonium phosphate+TX, butylcyclothion+TX, furothiocarb+TX, pyrethroid+TX, biguanide salt+TX, biguanide acetate+TX, sodium tetrathiocarbonate+TX, halfenp rox)+TX, HCH+TX, HEOD+TX, heptachlor+TX, cypermethrin+TX, HHDN+TX, hydrogen cyanide+TX, quinolinecarb+TX, IPSP+TX, chlorfenapyr+TX, carbon chlorine+TX, isoaldrin+TX, isofenphos+TX, transplanting spirit+TX, rice blast+TX, oxazophos+TX, juvenile hormone I+TX, juvenile hormone II+TX, juvenile hormone III+TX, chlorpentyl+TX, methoprene+TX, lead arsenate+TX, bromophenylphos+TX, acetamiprid+TX, thiamethoxam+TX, m-isopropyl methylcarbamate+TX, magnesium phosphide+TX, phosphorus azide+TX, methyl aphidron+TX, aphidron+TX, mercurous chloride+TX, methyl sulfoxide+TX,Metam+TX, Metam potassium salt+TX, Metam sodium salt+TX, methylsulfonyl fluoride+TX, butenamidophos+TX, methoprene+TX, methylthiothrin+TX, methoxychlor+TX, methyl isothiocyanate+TX, methyl chloroform+TX, dichloromethane+TX, oxadiazine+TX, anthelmintic+TX, naphthiophos+TX, naphthalene+TX, NC-170+TX, nicotine+TX, nicotine sulfate+TX, nithiazine+TX, orthonicotine+TX, O-5-dimethoate Chloro-4-iodophenyl O-ethylethylphosphonothioate + TX, O,O-diethyl O-4-methyl-2-oxo-2H-benzopyran-7-ylphosphonothioate + TX, O,O-diethyl O-6-methyl-2-propylpyrimidin-4-ylphosphonothioate + TX, O,O,O',O'-tetrapropyl dithiodipyrophosphate + TX, oleic acid + TX, p-dichlorobenzene + TX, methyl parathion + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, PH 60-38+TX, fenthion+TX, parathion+TX, phosphine+TX, methyl phoxim+TX, methamidophos+TX, polychlorinated dicyclopentadiene isomers+TX, potassium arsenite+TX, potassium thiocyanate+TX, precocious element I+TX, precocious element II+TX, precocious element III+TX, amidopyrimidin+TX, profluthrin+TX, fenthion+TX, pyraclostrobin+TX, anti-pyrethroid+TX, quassia extract+TX , quinalphos-methyl + TX, oxazolidinone + TX, iodophos + TX, resmethrin + TX, rotenone + TX, thiamethoxam + TX, ryanodine + TX, sabadilla + TX, octamethrin + TX, clostridium + TX, SI-0009 + TX, thiamethoxam + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoride + TX, sodium hexafluorosilicate + TX, sodium pentachlorophenol + TX, sodium selenate + TX, sodium thiocyanate + TX , sulcofuron + TX, sulcofuron-sodium + TX, sulfuryl fluoride + TX, thiopromide + TX, tar + TX, thiamethoxam + TX, TDE + TX, butylpyrimidinphos + TX, dimethophos + TX, cyclopentylthrin + TX, tetrachloroethane + TX, thiochlorvos + TX, cypermethrin + TX, cypermethrin oxalate + TX, cypermethrin + TX, cypermethrin sodium + TX, tralomethrin +TX, trans-permethrin +TX, trichlormetaphos-3 +TX, chlorpyrifos +TX, chloranil +TX, tolprocarb +TX, chlorpyrifos +TX, methoxam +TX, veratridine +TX, veratridine +TX, XMC +TX, zetamethrin +TX, zinc phosphide +TX, tolfenphos +TX, and chlorfenapyr +TX,Tetrafluthrin + TX, bis(tributyltin) oxide + TX, bromoacetamide + TX, ferric phosphate + TX, niclosamide-ethanolamine + TX, tributyltin oxide + TX, pyromorph + TX, snail killer + TX, 1,2-dibromo-3-chloropropane + TX, 1,3-dichloropropylene + TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide + TX, 3-(4-chlorophenyl)-5-methylrhodanine + TX, 5-methyl-6-thioxo-1,3,5-thiadiazin-3-yl acetic acid + TX, 6-isopentenylaminopurine +TX, 2-fluoro-N-(3-methoxyphenyl)-9H-purine-6-amine +TX, benclothiaz +TX, cytokinin +TX, DCIP +TX, furfural +TX, isamidophos +TX, kinetin +TX, verrucosporium mycorrhizal composition +TX, tetrachlorothiophene +TX, xylenol +TX, zeatin +TX, potassium ethylxanthate +TX, acibenzolar +TX, acibenzolar-S-methyl +TX, Reynoutria sachalinensis) extract + TX, α-chlorohydrin + TX, Antu + TX, barium carbonate + TX, bismuth urea + TX, brodifacoum + TX, brodifacoum + TX, brodifacoum + TX, chlordifacoum + TX, cholecalciferol + TX, chlorfenapyr + TX, clofodine + TX, clofodine + TX, clofodine + TX, clofodine + TX, clofodine + TX, clofodine + TX, clofodine + TX, calciferol + TX, fludioxaline + TX, fluoroacetamide + TX, fludioxaline +TX, flumethrin hydrochloride +TX, warfarin +TX, fosfos +TX, phosphorus +TX, warfarin +TX, warfarin +TX, scilla glycoside +TX, sodium fluoroacetate +TX, thallium sulfate +TX, warfarin +TX, 2-(-2-butoxyethoxy)ethyl piperate +TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone +TX, farnesol with nerolidol +TX, synergistic acetylene ether +TX, MGK 264 +TX, synergistic ether +TX, synergistic aldehyde +TX, synergistic ester (propyl isomer)+TX, S421+TX, Zengxiaosan+TX, sesasmolin+TX, sulfoxide+TX, anthraquinone+TX, copper cyclohexaneate+TX, copper oxychloride+TX, dicyclopentadiene+TX, serene+TX, zinc cyclohexaneate+TX, zinc thiram+TX, imanin+TX, ribavirin+TX, chloroindole hydrazide+TX, mercuric oxide+TX, thiophanate-methyl+TX, azaconazole+TX, bifenthrin+TX, oxadiazole+TX, cyproconazole+TX, fenpropimorph+TX, diniconazole+TX, epoxiconazole+TX, nitrobenzazole+TX, fluquinconazole+TX, fluquinconazole+TX, flusilazole+TX, flutriafol+TX, furopyram+TX, hexaconazole+TX, imazalil+TX, imidazole+TX, cyproconazole+TX, metconazole+TX, myclobutanil+TX,Paclobutrazol + TX, pyriclobutrazol + TX, penconazole + TX, prothioconazole + TX, pyrifenox + TX, prochloraz + TX, propiconazole + TX, pyraclostrobin + TX, simeconazole + TX, tebuconazole + TX, fluconazole + TX, triadimefon + TX, triadimenol + TX, triflumizole + TX, trichlorfon + TX, pyrimidine + TX, chlorfenapyr + TX, flufenapyr + TX, bupirimate + TX, dimethirimol + TX, ethirimol + TX, dodecacyclic morpholine + TX, fenpropidin + TX, butadiene Benzomorph + TX, spiroxafil + TX, tridemorph + TX, cyprodinil + TX, pyraclostrobin + TX, pyrimethanil + TX; fenpiclonil + TX, fludioxonil + TX, benalaxyl + TX, furalaxyl + TX, metalaxyl + TX, R-metalaxyl + TX; furamide + TX; oxadixyl + TX, carbendazim + TX, debacarb + TX, chloramphenicol + TX, thiabendazole + TX, chlozolinate + TX, dichlozoline + TX, myclozoline + TX , procymidone + TX, vinclozoline + TX, boscalid + TX, carboxin + TX, furamide + TX, flutolanil + TX, oxacarb + TX, penthiopyrad + TX, thiofuran + TX, dodine + TX, biguanide + TX, azoxystrobin + TX, enestroburin + TX, enestroburin + TX, flutoxanil + TX, fluoxastrobin + TX, enestroburin + TX, oxacarb + TX, oxacarb + TX, pyraclostrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, Strombolin + TX, pyraclostrobin + TX, pyraclostrobin + TX, pyraclostrobin + TX, ferbam + TX, mancozeb + TX, maneb + ​​TX, methanamide + TX, mancozeb + TX, mancozeb + TX, captol + TX, captan + TX, flurbiprofen + TX, folpet + TX, tolylfluanid + TX, Bordeaux mixture + TX, copper oxide + TX, mancozeb + TX, quinoline copper + TX, phthalostrobin + TX, kefansan + TX, isoblastin + TX, chlorpyrifos + TX, tolclofos-methyl + TX, captol + TX, benzathine + TX, blasticidin + TX, chloroneb + ​​TX, thiophanate-methyl + TX,Cymoxanil + TX, cyclobutrifluram + TX, diclocymet + TX, diclomezine + TX, dicloran + TX, diethofencarb + TX, oxadiazine + TX, flumorph + TX, dithianon + TX, ethaboxam + TX, etridiazole + TX, famoxadone + TX, fenamidone + TX, fenoxanil + TX, ferimzon e)+TX, fluazinam+TX, fluopicolide+TX, flusulfamide+TX, fluopyram+TX, fenoxam+TX, fosetyl-aluminium+TX, hymexazol+TX, propineb+TX, cyazofamid+TX, methasulfocarb+TX, metrafenone+TX, pencycuron+TX, phthalide+TX, polyoxins+TX, propamocarb b) + TX, pyraclostrobin + TX, proquinazid + TX, pyroquilon + TX, pyriofenone + TX, quinoxyfen + TX, pentachloronitrobenzene + TX, thiazolamide + TX, triazoxide + TX, tricyclazole + TX, trifenazone + TX, validamycin + TX, valeramide + TX, zoxamide + TX, mandipropamid + TX, fluphenazine + TX, isopyrazam + TX, sedaxane + TX, benzovintriazole +TX, fluopicolide +TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide +TX, isoflurane +TX, isothiopyram +TX, dipymetitrone +TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2-c]isothiazole-3-carbonitrile +TX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide +TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile +TX,(R)-3-(Difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine + TX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine + TX, fluindapyr + TX, jiaxiangjunzhi + TX, lvbenmixianan + TX, dichlobentiazox + TX, Man Mandestrobin + TX, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]phenyl]propan-2-ol + TX, oxathiapiprolin + TX, N-[6-[[[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamic acid tert-butyl ester + TX, pyraziflumid + TX, inpyrfluxam + TX, trolproca rb) + TX, chlorfluanidazole + TX, ipfentrifluconazole + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidinyl]thiazol-4-yl]-4,5 -dihydroisoxazol-5-yl]-3-chloro-phenyl] methanesulfonate + TX, N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamic acid but-3-ynyl ester + TX, N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamic acid methyl ester + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, pyridachlometyl + TX, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX,1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, aminopyrifen + TX, pyraclostrobin + TX, indazolesulfamide + TX, fluopyrafen + TX, (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX, pyrithione + TX, fenpyroxanamide + TX Fenpicoxamid + TX, isobutylethoxyquinoline + TX, ipflufenoquin + TX, quinofumelin + TX, isoproterenol + TX, N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, benzathiapiprolin + TX, cyproconazole + TX, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1) + TX, fluopyram amide + TX, fluthiazolinil + TX, fluopyramide + TX, pyrapropoyne + TX, picarbutrazox + TX, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, methotrexate (metyltetraprole) + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, α-(1,1-dimethylethyl)-α-[4'-(trifluoromethoxy)[1,1'-diphenyl]-4-yl]-5-pyrimidinemethanol + TX, fluoxapiprolin + TX, enoxastrobin + TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX,4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile+TX, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thio-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile+TX, anti-invertase+TX, syringoxystrobin+TX, zhongshengmycin+TX, thiophanate-copper+TX, thiazole zinc+TX, amectotractin+TX, isoprodinil+TX, N-octyl-N'-[2-(octylamino)ethyl]ethane-1,2-diamine+TX; N'-[5-bromo-2-methyl-6-[(1S)-1- [methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared by WO 2015 / 155075); N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared by the method described in IPCOM000249876D); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds can be prepared by the method described in WO 2018 / 228896); N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)oxetane-2-yl]phenyl]-N-methyl-formamidine + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine + TX (these compounds can be prepared by the method described in WO 2019 / 110427); N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX,N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, 8-fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide+TX, 8-fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide+TX, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide+TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide+TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide+TX, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide+TX (these compounds can be prepared by WO 2017 / 153380);

[0201] 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline+TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline+TX, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline+TX, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline+TX, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline+TX (these compounds can be prepared by WO 2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole + TX (these compounds can be prepared by WO 2016 / 156085); [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(3-hydroxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate+TX, [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate+TX, [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate+TX, [(1S,2S)-2-(4-fluoro-2-methyl [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl](2S)-2-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]propanoate+TX, [(1S,2S)-2-(4-fluoro-2-methyl-phenyl)-1,3-dimethyl-butyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate+TX, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide + TX, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide + TX, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea + TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl 4-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one+TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea+TX, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide+TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one+TX, [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one+TX, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester+TX, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine+TX. The compounds in this paragraph can be prepared by the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol+TX (this compound can be prepared by the method described in WO 2017 / 029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol+TX (this compound can be prepared by the method described in WO 2017 / 029179);4-triazol-1-yl)propan-2-ol+TX (this compound can be prepared by the method described in WO 2017 / 029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile+TX (this compound can be prepared by the method described in WO 2016 / 156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile+TX (this compound can be prepared by the method described in WO 2016 / 156290); 2-amino-6-methyl-pyridine-3-carboxylic acid (4-phenoxyphenyl) methyl ester+TX (this compound can be prepared by the method described in WO 2014 / 006945); 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetraone+TX (this compound can be prepared by the method described in WO2011 / 138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide+TX; N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide+TX; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide+TX (this compound can be prepared by the method described in WO 2018 / 153707); N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX; N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine + TX (this compound can be prepared by the method described in WO 2016 / 202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX (this compound can be prepared by the method described in WO 2-Oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide+TX (this compound can be prepared by the method described in WO 2018 / 065414); 1-[[5 ...4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylic acid ethyl ester + TX (this compound can be prepared by the method described in WO 2018 / 158365); 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide + TX, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N-[N-methoxy-C-methyl-carbonimino]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX (these compounds can be prepared by the method described in WO 2018 / 202428), biostimulants (Quantis, TM )(which contains organic carbon, nutrients and amino acids)+TX.

[0202] References in brackets after the active ingredients, e.g. [3878-19-1], refer to Chemical Abstracts registration numbers. The mixed compatibilities described above are known. In the case where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; 13th edition; Editor: CDSTomLin; The British Crop Protection Coimcil], they are described therein by the entry number given in parentheses above for the specific compound; e.g. the compound "avermectin" is described by entry number (1). In the case where "[CCN]" is added above to a specific compound, the compound in question is included in the "Compendium of Pesticide Common Names", which can be found on the Internet [A.Wood; Compendiumof PesticideCommonNames , 1995-2004]; for example, the compound "acetoprolin" is described on the Internet at http: / / www.alanwood.net / pesticides / acetoprole.html

[0203] Most of the above-mentioned active ingredients are referred to above by so-called "common names", in individual cases the corresponding "ISO common name" or another "common name" being used. If a name is not a "common name", the kind of name used is replaced by the name given in parentheses for the specific compound; in this case, the IUPAC name, IUPAC / Chemical Abstracts name, "Chemical Name", "Conventional Name", "Compound Name" or "Development Code" is used, or, if neither one of those names nor the "common name" is used, an "alternative name" is used. "CAS Registry Number" means the Chemical Abstracts Registry Number.

[0204] In the "reference" mixture composition, the mixture of a compound of formula (I) (selected from Table X (above)) and the active ingredient described above comprises a compound selected from Table X (above) and the active ingredient as described above, preferably in a mixing ratio of from 100:1 to 1:100, especially from 50:1 to 1:50, more especially in a ratio of from 20:1 to 1:20, even more especially from 10:1 to 1:10, yet even more especially from 7.5:1 to 1:7.5, very especially from 5:1 and 1:5, particularly preferably in a ratio of from 2:1 to 1:2, and a ratio of from 4:1 to 2:1 is likewise preferred, especially in a ratio of 1: 1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4:2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500, or 1:350, or 2:350, or 4:350, or 1:750, or 2:750, or 4:750. Those mixing ratios are by weight.

[0205] These mixed compositions as described above (both according to the invention and the "reference" mixed compositions) can be used in a method of controlling pests, which method comprises applying a composition containing the mixture as described above to the pests or their environment.

[0206] Mixtures comprising a compound of formula (I) selected from Table X (above) and one or more active ingredients as described above can be applied, for example, in a single "ready-to-use" form, as a combined spray mixture consisting of separate formulations of the single active ingredients (such as a "tank mix"), and applied in combination with the separate active ingredients when applied in a sequential manner (i.e., one after another reasonably short period of time, such as a few hours or days). The order of applying the compounds of formula (I) selected from Table X (above) and the active ingredients as described above is not important for practicing the present invention.

[0207] The compositions of the invention may also be used for crop enhancement. According to the invention, 'crop enhancement' means improvement in plant vigour, improvement in plant quality, improved tolerance to stress factors and / or improved efficiency of input use.

[0208] According to the present invention, 'improvement of plant vigour' means that certain traits are improved qualitatively or quantitatively when compared to the same traits in control plants which have been grown under the same conditions but without the method of the present invention. Such traits include, but are not limited to, early and / or improved germination, improved emergence, ability to use less seed, increased root growth, more developed root system, increased root nodulation, increased shoot growth, increased tillering, stronger tillering, more efficient tillering, increased or improved plant stand, less plant verse (lodging), increased and / or improved plant height, increased plant weight (fresh or dry weight), larger leaves, greener leaf color, increased pigment content, increased photosynthetic activity, earlier flowering, longer panicles, early grain maturity, increased seed, fruit or pod size, increased number of pods or ears, increased number of seeds per pod or ear, increased seed quality, enhanced seed filling, fewer dead basal leaves, delayed wilt, improved plant vigour, increased amino acid compound levels in storage tissues and / or fewer inputs required (e.g., less fertilizer, water and / or labor required). A plant with improved vigor may have an increase in any of the above traits or in any combination or two or more of the above traits.

[0209] According to the present invention, 'improvement of plant quality' means that certain traits are improved qualitatively or quantitatively when compared to the same traits in control plants which have been grown under the same conditions but without the method of the present invention. Such traits include, but are not limited to, improved visual appearance of plants, reduced ethylene (reduced production and / or inhibited uptake), improved quality of harvested material (e.g., seeds, fruits, leaves, vegetables), (such improved quality can be manifested as improved visual appearance of harvested material, improved carbohydrate content (e.g., increased amount of sugar and / or starch, improved sugar-acid ratio, reduction of reducing sugars, increased rate of sugar formation), improved protein content, improved oil content and composition, improved nutritional value, reduction of anti-nutritional compounds, improved organoleptic properties (e.g., improved taste) and / or improved consumer health benefits (e.g., increased vitamin and antioxidant levels)), improved post-harvest characteristics (e.g., enhanced shelf life and / or storage stability, easier processability, easier compound extraction), more homogeneous crop development (e.g., simultaneous germination, flowering and / or fruiting of plants) and / or improved seed quality (e.g., for use in subsequent seasons). Plants with improved quality can have an increase in any of the above traits or any combination or two or more of the above traits.

[0210] According to the present invention, the tolerance improvement of stress factors means that some characters are qualitatively or quantitatively improved when compared with the same characters of the control plants under the same conditions lacking the inventive method. Such characters include but are not limited to the tolerance and / or resistance increase to multiple abiotic stress factors, which cause suboptimal growth conditions, such as drought (for example causing plant water content to lack, water absorption potential to lack or any stress to reduce water supply to plants), cold, heated, osmotic stress, UV stress, flooding, salinity increase (for example salinity in the soil), increased mineral exposure, ozone exposure, high light exposure and / or nutrient (for example nitrogen and / or phosphorus nutrient) utilization is limited. Plants that the tolerance to stress factors is improved can have an increase in any of the above-mentioned characters or any combination or two or more of the above-mentioned characters. In the case of drought and nutrient stress, these tolerance improvements can be attributed to, for example, more efficient absorption, utilization or retention of moisture and nutrients.

[0211] According to the present invention, 'improved input utilization efficiency' means that the plant is able to grow using a given level of inputs more efficiently when compared to the growth of a control plant grown under the same conditions but without the method of the present invention. Specifically, these inputs include, but are not limited to, fertilizers (such as nitrogen, phosphorus, potassium, micronutrients), light and water. Plants with improved input utilization efficiency can have improved use of any of the above inputs, or any combination of two or more of the above inputs.

[0212] Other crop enhancements of the present invention include reduced plant height, or reduced tillering, which are beneficial traits in crops or under conditions where it is desirable to have less biomass and fewer tillers.

[0213] Any or all of the above crop enhancements may result in improved yields by improving, for example, plant physiology, plant growth and development and / or plant architecture. In the context of the present invention, 'yield' includes, but is not limited to: (i) an increase in biomass production, grain yield, starch content, oil content and / or protein content, which may result from: (a) an increase in the amount produced by the plant itself or (b) an improved ability to harvest plant matter, (ii) an improvement in the composition of the harvested material (e.g., improved sugar-acid ratio, improved oil composition, increased nutritional value, reduction in anti-nutritional compounds, increased consumer health benefits) and / or (iii) an increased / facilitated ability to harvest crops, improved crop processability and / or better storage stability / shelf life. Increased yield of agricultural plants means that, where quantitative measurements can be taken, the yield of a product of each plant is increased by a measurable amount over the yield of the same product produced by the plant under the same conditions (but without the application of the present invention). According to the present invention, preferably the yield is increased by at least 0.5%, more preferably at least 1%, even more preferably at least 2%, still more preferably at least 4%, preferably 5% or even higher.

[0214] Any or all of the above crop enhancements can also lead to improved land use, i.e., land that was previously unavailable or suboptimal for planting can become available. For example, plants that show increased ability to survive under drought conditions can be grown in suboptimal rainfall areas (e.g., perhaps on the edge of a desert or even in a desert).

[0215] In one aspect of the invention, crop enhancement is obtained in the absence of pressure from harmful organisms and / or diseases and / or abiotic stress. In another aspect of the invention, improvements in plant vigor, stress tolerance, quality and / or yield are obtained in the absence of pressure from harmful organisms and / or diseases. For example, harmful organisms and / or diseases can be controlled by applying pesticidal treatments before the method of the present invention, or simultaneously. In yet another aspect of the invention, improvements in plant vigor, stress tolerance, quality and / or yield are obtained in the absence of harmful organisms and / or disease pressure. In further embodiments, improvements in plant vigor, quality and / or yield are obtained in the absence or absence of abiotic stress.

[0216] These compositions of the present invention can also be used in the field of protecting stored goods from fungal attack. According to the present invention, the term "stored goods" should be understood as natural substances and processed forms thereof representing plants and / or animal origin, which are taken from the natural life cycle and which are desired to be used for long-term protection. Stored goods of plant origin (such as plants or parts thereof (such as, stalks, leaves, tubers, seeds, fruits or grains)) can be protected in the state of fresh harvest or in processed forms (such as pre-dried, moistened, crushed, ground or baked). Also falling under the definition of stored goods is wood, whether in the form of logs, such as building timber, transmission towers and fences, or in the form of finished products, such as furniture or objects made from wood. Stored goods of animal origin are hides, leather, fur, hair, etc. According to the composition of the present invention, adverse effects can be prevented, such as corruption, fading or mildew. Preferably, "stored goods" should be understood as natural substances and / or processed forms thereof representing plants, more preferably fruits and processed forms thereof (such as pears, drupes, berries and citrus and processed forms thereof). In another preferred embodiment of the present invention, "stored goods" is understood to mean wood.

[0217] Therefore, another aspect of the present invention is a method for protecting stored goods, which method comprises applying a composition according to the present invention to stored goods.

[0218] The composition according to the invention can also be used in the field of protecting technical materials from fungal attack. According to the invention, the term "technical material" includes paper; carpets; buildings; cooling and heating systems; wallboards; ventilation and air conditioning systems, etc.; preferably, "technical material" is understood to mean wallboards. The composition according to the invention can prevent adverse effects such as decay, discoloration or mold.

[0219] The compositions according to the invention are usually formulated in a variety of ways using formulation adjuvants such as carriers, solvents and surface-active substances. These formulations may be in different physical forms, for example in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent compressed tablets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, flowable oils, aqueous dispersions, oily dispersions, suspoemulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or water-miscible organic solvents as carriers), impregnated polymer films or in other forms known, for example, from Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, 1st edition, second revision (2010). Such formulations can be used directly or can be diluted before use. Dilution can be carried out with, for example, water, liquid fertilizers, micronutrients, biological organisms, oils or solvents.

[0220] These formulations can be prepared, for example, by mixing the active ingredient with a formulation adjuvant in order to obtain a composition in the form of a finely divided solid, granules, solution, dispersion or emulsion. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of plant or animal origin, modified oils of plant or animal origin, organic solvents, water, surface-active substances or combinations thereof.

[0221] These active ingredients can also be contained in microcapsules. Microcapsules contain active ingredients in porous carriers. This allows the active ingredients to be released (e.g., slowly released) into the environment in a controlled amount. Microcapsules typically have a diameter of from 0.1 to 500 microns. The amount of active ingredients they contain is about 25% to 95% of the capsule weight by weight. These active ingredients can be in the form of an integral solid, in the form of fine particles in a solid or liquid dispersion, or in the form of a suitable solution. The encapsulated film can include, for example, natural or synthetic rubber, cellulose, styrene / butadiene copolymers, polyacrylonitrile, polyacrylate, polyester, polyamide, polyurea, polyurethane or chemically modified polymers and starch xanthate or other polymers known to those skilled in the art. Alternatively, very fine microcapsules can be formed, in which the active ingredients are contained in the form of finely dispersed particles in a solid matrix of a base material, but these microcapsules themselves are not wrapped.

[0222] Formulation auxiliaries suitable for preparing the formulations according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol rosinate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl Formamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, dipropylene glycol, alkyl pyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, α-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, γ-butyrolactone, glycerol, acetic acid glyceryl, diacetic acid glyceryl, triacetin, decaglycerol Hexadecane, hexanediol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, cumene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxypropanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, dichloromethane, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate , propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol and higher molecular weight alcohols such as amyl alcohol, tetrahydrofuranol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone, etc.

[0223] Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, diatomaceous earth, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed hulls, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.

[0224] Many surface-active substances can be used advantageously in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier before use. Surface-active substances can be anionic, cationic, nonionic or polymeric and they can act as emulsifying agents, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium dodecylsulfate; salts of alkylarylsulfonates, such as calcium dodecylbenzenesulfonate; alkylphenol / alkylene oxide addition products, such as ethoxylated nonylphenol; alcohol / alkylene oxide addition products, such as ethoxylated tridecanol; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; salts of dialkyl sulfosuccinates, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitan oleate; quaternary ammoniums, such as dodecyltrimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphates; and also further substances, such as are described, for example, in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Company. Corp., Ridgewood New Jersey (1981).

[0225] Additional adjuvants that can be used in pesticidal formulations include crystallization inhibitors, viscosity modifiers, suspending agents, dyes, antioxidants, foaming agents, light absorbers, mixing aids, defoamers, complexing agents, substances and buffers that neutralize or change the pH, corrosion inhibitors, fragrances, wetting agents, absorption enhancers, micronutrients, plasticizers, glidants, lubricants, dispersants, thickeners, antifreeze agents, microbicides, and liquid and solid fertilizers.

[0226] The formulation according to the invention may comprise an additive comprising an oil of plant or animal origin, a mineral oil, an alkyl ester of such an oil or a mixture of such an oil with an oil derivative. The amount of the oil additive in the formulation according to the invention is generally from 0.01% to 10% based on the mixture to be applied. For example, the oil additive can be added to the spray tank in the desired concentration after the spray mixture has been prepared. Preferred oil additives include mineral oil or oil of plant origin, such as rapeseed oil, olive oil or sunflower oil; emulsified vegetable oils; alkyl esters of oils of plant origin, such as methyl derivatives; or oils of animal origin, such as fish oil or tallow. Preferred oil additives include C8-C 22 Alkyl esters of fatty acids, especially C 12 -C 18Methyl derivatives of fatty acids, such as the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10th edition, Southern Illinois University, 2010.

[0227] These formulations usually contain from 0.1% to 99% by weight, in particular from 0.1% to 95% by weight, of the compounds of component (A) and component (B) and from 1% to 99.9% by weight of formulation auxiliaries, which preferably include from 0 to 25% by weight of surface-active substances. Whereas commercial products may preferably be formulated as concentrates, the end user will generally use dilute formulations.

[0228] The application rate varies within a wide range and depends on the nature of the soil, the application method, the crop plants, the harmful organisms to be controlled, the prevailing climatic conditions, and other factors governed by the application method, the application time and the target crop. In general, the compound can be applied at a rate of from 1 l / ha to 2000 l / ha, especially from 10 l / ha to 1000 l / ha.

[0229] Certain mixture compositions comprising compounds of formula (I) described above may show synergistic effects. Such synergistic effects occur whenever the effect of the active ingredient combination is greater than the sum of the effects of the individual components. For a given active ingredient combination, the expected effect E obeys the so-called COLBY formula and can be calculated as follows (COLBY, SR "Calculating synergistic and antagonistic responses of herbicide combination". Weeds [weeds], Vol. 15, pp. 20-22; 1967):

[0230] ppm = milligrams of active ingredient (=ai) per liter of spray mixture

[0231] X = % effect based on active ingredient A) using p ppm of active ingredient

[0232] Y = % effect based on active ingredient B) using q ppm of active ingredient.

[0233] According to Kolby, using p+q ppm of active ingredient, the expected (additive) effect of active ingredient A) + B) is:

[0234]

[0235] If the effect actually observed (O) is greater than the expected effect (E), then the effect of the combination is superadditive, i.e. there is a synergistic effect. In mathematical terms, synergy corresponds to a positive value of the difference (OE). In the case of purely complementary additions of actives (expected activity), the difference (OE) is zero. Negative values ​​of the difference (OE) indicate a loss of activity compared to the expected activity.

[0236] However, in addition to the actual synergistic effect with respect to the fungicidal activity, the compositions according to the invention may also have further unexpected advantageous properties. Examples of such advantageous properties that may be mentioned are: more favorable degradability; improved toxicological and / or ecotoxicological behavior; or improved characteristics of useful plants, including: emergence, crop yield, more developed root system, increased tillering, increased plant height, larger leaves, less basal leaf death, stronger tillering, greener leaf color, less fertilizer required, less seed required, more productive tillering, earlier flowering, earlier grain maturity, less plant lodging (lodging), enhanced shoot growth, improved plant vigor and early germination.

[0237] The compositions according to the invention can be applied to phytopathogenic microorganisms, useful plants, their locus, their propagation material, stored goods or technological materials threatened by attack by microorganisms.

[0238] The compositions according to the invention can be applied before or after the useful plants, their propagation material, stored goods or technical material have been infected with the microorganisms.

[0239] The amount of the composition according to the invention to be applied will depend on various factors, such as the compound used; the object of treatment, such as, for example, plants, soil or seeds; the type of treatment, such as, for example, spraying, dusting or seed dressing; the purpose of the treatment, such as, for example, prevention or treatment; the type of fungus to be controlled or the time of application.

[0240] Typically, component (A) is typically applied at a rate of 5 to 2000 g ai / ha, in particular 10 to 1000 g ai / ha, for example 50 g ai / ha, 75 g ai / ha, 100 g ai / ha or 200 g ai / ha when applied to useful plants in combination with component (B) at a rate of typically 1 to 5000 g ai / ha, in particular 2 to 2000 g ai / ha, for example 100 g ai. / ha, 250 g ai / ha, 500 g ai / ha, 800 g ai / ha, 1000 g ai. / ha, 1500 g ai / ha.

[0241] In agricultural practice, the application rates of the compositions according to the invention depend on the type of action desired and typically range from 20 to 4000 g of total composition per hectare.

[0242] When the composition according to the invention is used to treat seed, a ratio of 0.001 to 50 g of compound of component (A) per kg of seed, preferably from 0.01 to 10 g per kg of seed, and 0.001 to 50 g of compound of component (B) per kg of seed, preferably from 0.01 to 10 g per kg of seed, is generally sufficient.

[0243] For the avoidance of doubt, where a literature reference, patent application, or patent is cited within the text of this application, the entirety of the reference is incorporated herein by reference.

[0244] Examples

[0245] The following examples are used to illustrate the present invention.

[0246] The compounds (and compositions) of the present invention can be distinguished from known compounds (and compositions) by greater efficacy at low application rates, which can be demonstrated by one skilled in the art using the experimental procedures outlined in the examples, using lower application rates (if necessary), for example, 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm or 0.2 ppm of one or more active ingredients.

[0247] Throughout this specification, temperatures are given in degrees Celsius and "mp" means melting point. LC / MS means liquid chromatography-mass spectrometry, and a description of the apparatus and methods is as follows:

[0248] Method G:

[0249] Spectra were recorded on a mass spectrometer from Waters (SQD, SQDII single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive and negative ions, capillary voltage: 3.00 kV, cone range: 30 V, extractor: 2.00 V, source temperature: 150°C, desolvation temperature: 350°C, cone gas flow: 50 l / h, desolvation gas flow: 650 L / h, mass range: 100 Da to 900 Da) and an Acquity UPLC from Waters: binary pump, heated column compartment, diode array detector and ELSD detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, temperature: 60° C., DAD wavelength range (nm): 210 to 500, solvent gradient: A=water+5% MeOH+0.05% HCOOH, B=acetonitrile+0.05% HCOOH; gradient: 10%-100% B in 1.2 min; flow rate (mL / min) 0.85.

[0250] Method H:

[0251] Spectra were recorded on a mass spectrometer from Waters (SQD, SQDII single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive and negative ions, capillary voltage: 3.00 kV, cone range: 30 V, extractor: 2.00 V, source temperature: 150°C, desolvation temperature: 350°C, cone gas flow: 50 L / h, desolvation gas flow: 650 L / h, mass range: 100 Da to 900 Da) and an Acquity UPLC from Waters: binary pump, heated column compartment, diode array detector and ELSD detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, temperature: 60° C., DAD wavelength range (nm): 210 to 500, solvent gradient: A=water+5% MeOH+0.05% HCOOH, B=acetonitrile+0.05% HCOOH; gradient: 10%-100% B in 2.7 min; flow rate (mL / min) 0.85.

[0252] If desired, enantiomerically pure final compounds can be obtained, where appropriate, from racemic materials via standard physical separation techniques (eg, reverse phase chiral chromatography) or by stereoselective synthetic techniques (eg, by using chiral starting materials).

[0253] Preparation Examples

[0254]

[0255] The active ingredient is mixed thoroughly with the adjuvant and the mixture is ground thoroughly in a suitable grinder to provide a wettable powder which can be diluted with water to give a suspension of the desired concentration.

[0256]

[0257] The active ingredient is thoroughly mixed with the adjuvant and the mixture is thoroughly ground in a suitable grinder to provide a dust that can be used directly for seed treatment.

[0258] Emulsifiable concentrates

[0259]

[0260] Emulsions of any desired dilution which can be used in plant protection can be obtained from these concentrates by dilution with water.

[0261]

[0262] Ready-to-use dusts are obtained by mixing the active ingredient with a carrier and grinding the mixture in a suitable grinder. Such dusts can also be used for dry seed dressing of seeds.

[0263] Extruder pellets

[0264]

[0265]

[0266] The active ingredient is mixed with the auxiliary agent and ground, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

[0267] Coated granules

[0268] Active ingredients [components (A) and (B)] 8%

[0269] Polyethylene glycol (molecular weight 200) 3%

[0270] Kaolin 89%

[0271] The finely ground active ingredient is applied uniformly in a mixer to the kaolin moistened with polyethylene glycol. In this way, dust-free coated granules are obtained.

[0272] Suspension concentrates

[0273]

[0274] The finely ground active ingredient is intimately mixed with adjuvants to give a suspension concentrate from which suspension concentrates of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants together with plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0275] Flowable concentrate for seed treatment

[0276]

[0277]

[0278] The finely ground active ingredient is intimately mixed with adjuvants to give a suspension concentrate from which suspension concentrates of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants together with plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0279] Extended-release capsule suspension

[0280] 28 parts of the combination of active ingredients [components (A) and (B)] are mixed with 2 parts of an aromatic solvent and 7 parts of a toluene diisocyanate / polymethylene-polyphenyl isocyanate mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is reached. To this emulsion are added 2.8 parts of a 1,6-hexanediamine mixture in 5.3 parts of water. The mixture is stirred until the polymerization reaction is complete. The capsule suspension obtained is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersant. The capsule suspension formulation contains 28% of active ingredients. The diameter of the medium capsules is 8-15 microns. The resulting formulation is applied to the seeds as an aqueous suspension in a device suitable for this purpose.

[0281] List of abbreviations:

[0282] Aq.=Water-based

[0283] br s = broad singlet

[0284] ℃ = degrees Celsius

[0285] DCM = dichloromethane

[0286] dd = doublet

[0287] DMF = dimethylformamide

[0288] DMSO = dimethyl sulfoxide

[0289] DMSO-d6 = deuterated dimethyl sulfoxide

[0290] d = doublet

[0291] EtOAc = Ethyl acetate

[0292] equiv. = equivalent

[0293] h = hours

[0294] M = mole

[0295] m = multiplet

[0296] min = minutes

[0297] MHz = Megahertz

[0298] mp = melting point

[0299] Pd2(dba)3 = tris(dibenzylideneacetone)dipalladium(0)

[0300] Pd(dppf)Cl2·DCM = [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), DCM complex

[0301] Pd(PPh3)2Cl2 = bis(triphenylphosphine)palladium(II) dichloride

[0302] ppm = parts per million

[0303] RT = Room temperature

[0304] R t =Retention time

[0305] s = single peak

[0306] t = triplet

[0307] THF = Tetrahydrofuran

[0308] LC / MS = Liquid Chromatography Mass Spectrometry (a description of the apparatus and methods for LC / MS analysis is given above)

[0309] X-Phos Pd G2 = Chloro(2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II)

[0310] Preparation Example:

[0311] Example 1:This example illustrates the preparation of (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.04)

[0312] Step 1: Preparation of methyl 2-(5-bromo-2-methyl-phenoxy)acetate

[0313]

[0314] To 5-bromo-2-methylphenol (53.47mmol, 10.00g) and 2-bromoacetic acid methyl ester (1.5 equivalents, 80.20mmol, 12.27g, 7.44mL) in tetrahydrofuran (0.5mol / L, 106.9mL) at room temperature, potassium carbonate (2 equivalents, 106.9mmol, 14.78g) is added, and the light brown suspension is heated to 65°C for 2h, then cooled to room temperature overnight. The reaction mixture is diluted with EtOAc and washed with water. The aqueous phase is extracted with EtOAc, and the total organic phase combined is washed with water, brine, dried over Na2SO4, filtered, and concentrated in vacuo to obtain 2-(5-bromo-2-methyl-phenoxy) acetic acid methyl ester (47.22mmol, 15.89g, 88% yield) in a brown liquid. The crude oil is slightly contaminated by residual 2-bromoacetic acid methyl ester, but is directly used in the next step without further purification.

[0315] LCMS (method H), Rt=1.59 min, MS: (M+1)=259,261; 1 H NMR

[0316] (400MHz, CDCl3) δppm 2.25 (s, 3H) 3.84 (s, 3H) 4.66 (s, 2H) 6.84 (d, 1H) 7.05 (m, 2H)

[0317] Step 2: Preparation of (Z)-2-(5-bromo-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester

[0318]

[0319] Part 1: To a solution of 2-(5-bromo-2-methylphenoxy)acetate (20.8 g, 80.3 mmol) and methyl formate (6.0 equiv., 482 mmol, 29.5 g, 30.5 mL) in tetrahydrofuran (0.5 mol / L, 161 mL) at room temperature under argon was added sodium methoxide (20 equiv., 161 mmol, 9.13 g) in batches. The reaction was slightly exothermic and was maintained below 30° C. with the help of a room temperature water bath. The reaction mixture was stirred at room temperature for 1 h and quenched by slowly adding a saturated aqueous solution of NaHCO. The two phases were separated and the aqueous phase was extracted with EtOAc. The total combined organic layer was washed with a saturated aqueous solution of NaHCO, brine, dried with NaSO, filtered and concentrated in vacuo to give methyl 2-(5-bromo-2-methyl-phenoxy)-3-hydroxy-prop-2-enoate, which was used directly in the next step without further purification.

[0320] LCMS (Method G), Rt = 0.80 and 0.90 min, MS: (M+1) = 287, 289

[0321] Part 2: To the solution of crude 2-(5-bromo-2-methyl-phenoxy)-3-hydroxy-prop-2-enoic acid methyl ester and dimethyl sulfate (1.2 equivalents, 93.2mmol, 11.8g, 8.8mL) in DMF (0.5mol / L, 155mL) at room temperature, potassium carbonate (1.5 equivalents, 117mmol, 16.3g) is added, and the reaction mixture is stirred at room temperature for 2h. The reaction mixture is quenched by slowly adding water, and the mixture is extracted with EtOAc. The total organic layer combined is washed with a saturated aqueous solution of NaHCO3, brine, Na2SO4 is dried, filtered and concentrated in a vacuum. The residue is purified by flash chromatography (cyclohexane: EtOAc) to obtain (Z)-2-(5-bromo-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (59.6mmol, 18.0g, 75% yield) as an off-white solid.

[0322] LCMS (Method G), Rt=1.02 min, MS: (M+1)=301,303; 1 H NMR

[0323] (400MHz,CDCl 3 )δppm 2.31(s,3H)3.74(s,3H)3.91(s,3H)6.86(d,1H)7.05(m,2H)7.35(s,1H)

[0324] Step 3: Preparation of (Z)-2-[5-(cyclohexen-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester preparation

[0325]

[0326] To a solution of (Z)-2-(5-bromo-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (203 mg, 0.67 mmol, 1.00 equiv) in 1,4-dioxane (6 mL) and water (1 mL) was added cyclohexene-1-ylboronic acid (93.4 mg, 0.74 mmol, 1.10 equiv), potassium phosphate (295 mg, 1.35 mmol, 2.00 equiv) and X Phos Pd G2 (53.0 mg, 0.07 mmol, 0.10 equiv). The reaction mixture was stirred at 100 ° C for 15 min and the heat source was removed. After the contents reached room temperature, they were diluted with EtOAc and saturated NaHCO3 aqueous solution and then extracted with EtOAc. All combined organic fractions were washed with saturated NaHCO3 aqueous solution and brine, dried over Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (cyclohexane:EtOAc) to give (Z)-2-[5-(cyclohexen-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester as an amorphous solid.

[0327] LC-MS (Method G), R t =1.17min,MS:(M+H)=303; 1 H NMR (400

[0328] MHz, CDCl3)δppm 7.36(s,1H),7.11(d,1H),6.96(dd,1H),6.77(d,1H),6.04(m,1H),3.90(s,3H),3 .74(s,3H),2.36(m,5H),2.17-2.25(m,2H),1.74-1.83(m,2H),1.63-1.71(m,2H).

[0329] Step 4: Preparation of (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.04)

[0330]

[0331] To a solution of (Z)-2-[5-(cyclohexene-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester (132 mg, 0.44 mmol, 1.00 equiv) in hexane (0.87 mL) and EtOAc (2.18 mL) was added palladium on carbon (23.2 mg, 0.01 mmol, 0.02 equiv). The reaction mixture was stirred under a hydrogen atmosphere for 2 days. The reaction mixture was filtered through celite and concentrated in vacuo. The resulting crude residue was purified by flash chromatography (cyclohexane: EtOAc) to give (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (mp: 131° C.-132° C.) as a white solid.

[0332] LC-MS (Method G), R t =1.21min,MS:(M+H)=305; 1 H NMR (400

[0333] MHz, CDCl3)δppm ppm 7.35(s,1H),7.10(d,1H),6.79(dd,1H),6.58(d,1H),3.90(s,3H),3.74(s,3H),2.38-2.47( m,1H),2.34(s,3H),1.80-1.89(m,4H),1.75(br,1H),1.33-1.42(m,4H),1.22-1.32(m,1H).

[0334] Example 2: This example illustrates the preparation of (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.02)

[0335]

[0336] Under argon atmosphere, 1M THF solution of zinc chloride (2.54mmol) is added in 2M THF solution (2.54mmol) of cyclopentylmagnesium bromide, and light yellow suspension is stirred at room temperature for 10min, and a small exothermic reaction is observed during this period. After this, solution and PdCl of (Z)-2-(5-bromo-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl esters (0.153g, 0.51mmol) in tetrahydrofuran (2.5mL) are added (dppf) (0.19g, 0.025mmol) and light yellow suspension is heated at 50 ℃ for 3 hours. Then the reaction mixture is made to reach room temperature, quenched with saturated NH4Cl aqueous solution, and extracted with methyl tert-butyl ether. Then the total organic part of merging is washed with water and salt water, dried over sodium sulfate, filtered and concentrated under reduced pressure. The resulting crude residue was purified by flash chromatography (cyclohexane:EtOAc gradient) to give 0.106 mg of the title compound as a white solid (mp 80-83° C.).

[0337] LC-MS (Method G), R t =1.16min,MS:(M+H)=291; 1 H NMR (400

[0338] MHz, CDCl3)δppm:7.35(s,1H),7.09(d,1H),6.82(d,1H),6.60(s,1H),3.90(s,3H),3.72(s,3H),2. 91(m,1H),2.32(s,3H),2.10-1.97(m,2H),1.85-1.75(m,2H),1.74-1.65(m,2H),1.60-1.45(m,2H).

[0339] Accordingly, compounds of formula (I) may be prepared using the synthetic techniques described above and below.

[0340] If desired, enantiomerically pure final compounds can be obtained, where appropriate, from racemic materials via standard physical separation techniques (eg, reverse phase chiral chromatography) or by stereoselective synthetic techniques (eg, by using chiral starting materials).

[0341] Table T1: Melting point (mp) data of compounds X.01 to X.04 according to formula (I) and / or Retention time (Rt):

[0342]

[0343]

[0344] Biological Examples:

[0345] General example of a blade disc test in an orifice plate:

[0346] Leaf discs or leaf segments of different plant species were cut from plants grown in a greenhouse. The cut leaf discs or leaf segments were placed on water agar in a multiwell plate (24-well format). The leaf discs were sprayed with the test solution before inoculation (preventive) or after (curative). The compound to be tested was prepared as a DMSO solution (maximum 10 mg / mL) and diluted to the appropriate concentration with 0.025% Tween20 just before spraying. The inoculated leaf discs or leaf segments were incubated under defined conditions (temperature, relative humidity, light, etc.) according to the corresponding test system. Depending on the disease system, a single assessment of the disease level was performed 3 to 14 days after inoculation. The disease control percentage relative to the untreated test leaf discs or leaf segments was then calculated.

[0347] General example of a liquid culture test in a well plate:

[0348] The mycelial fragments or conidia suspensions of the fungus (freshly prepared from the liquid culture of the fungus or from low temperature storage) are directly mixed into the nutrient broth. The DMSO solution of the test compound (maximum 10 mg / mL) is diluted 50 times with 0.025% Tween20, and 10 μl of this solution is pipetted into a microtiter plate (96-well specification). Then the nutrient broth containing the fungal spore / mycelial fragments is added thereto to obtain the final concentration of the test compound. The test plate is incubated in the dark at 24°C and 96% relative humidity. Depending on the disease system, the inhibition of fungal growth is determined photometrically after 2 to 7 days, and the antifungal activity percentage relative to the untreated test object is calculated.

[0349] Example A1: Fungicidal activity against Puccinia recondita f. sp. tritici Active / Wheat / Leaf Disc Prevention (Brown Rust)

[0350] Wheat leaf segments were placed on agar in a multiwell plate (24-well format) and sprayed with the test solution. After drying, the leaf segments were inoculated with a spore suspension of the fungus. After appropriate incubation, the activity of the compound 8 dpi (days after incubation) was assessed as preventive fungicidal activity.

[0351] The following compounds gave at least 80% control of Puccinia reconditatis of wheat at 200 ppm when compared to untreated controls showing extensive disease development under the same conditions:

[0352] Compounds (from Table T1): X.01, X.02, X.03, X.04

[0353] Example A2: Fungicidal activity against Puccinia reconditatis / wheat / leaf disc treatment (brown rust)

[0354] Wheat leaf segments were placed on agar in a multiwell plate (24-well format). The leaf segments were inoculated with a spore suspension of the fungus and sprayed with the test solution 1 day after inoculation. After appropriate incubation, the activity of the compound 8 dpi (days after incubation) was assessed as curative fungicidal activity.

[0355] The following compounds gave at least 80% control of Puccinia reconditatis of wheat at 200 ppm when compared to untreated controls showing extensive disease development under the same conditions:

[0356] Compounds (from Table T1): X.01, X.02, X.04

[0357] Example A3: Fungicidal activity against Phakopsora pachyrhizi / soybean / leaf disc preventive method (Asian soybean rust)

[0358] Soybean leaf disks were placed on agar in a multiwell plate (24-well format) and sprayed with the test solution. After drying, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation, the activity of the compound about 12 dpi (days after incubation) was assessed as preventive fungicidal activity.

[0359] The following compounds gave at least 70% control of Phakopsora pachyrhizi at 60 ppm when compared to untreated controls showing extensive disease development under the same conditions:

[0360] Compounds (from Table T1): X.01, X.02, X.03, X.04

[0361] Example A4: Against Glomerella lagenarium (Cucurbit Anthracnose Fungicidal activity of liquid cultures of (Colletotrichum lagenarium) / cucumber / preventive measures (anthracnose)

[0362] Fungal conidia from frozen storage were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and the inhibition of growth was determined photometrically at 620nm after 72 hours.

[0363] The following compounds at 20 ppm gave at least 80% control of Aspergillus niger when compared to untreated controls which showed extensive disease development under the same conditions:

[0364] Compounds (from Table T1): X.01, X.02, X.03, X.04

[0365] Comparison data:

[0366] The biological activities of the compounds X.02 and X.04 of the present invention were compared with reference compounds Z-1 and Z-2. Reference compounds Z-1 and Z-2 are specifically disclosed on page 16 of WO 98 / 03464 and on page 6 of EP 0 212 859, respectively.

[0367] Example B: Comparative biological activity against Puccinia recondita (brown rust) of wheat, curative:

[0368] Method: Wheat leaf segments were placed on agar in multiwell plates (24-well format). The leaf segments were inoculated with a spore suspension of the fungus and sprayed with the test solution 1 day after inoculation. After appropriate incubation, the activity of the compound 8 dpi (days after incubation) was assessed as curative fungicidal activity.

[0369] The data are expressed as percent disease control and test rate for each compound in the biological assay described in Table B1 below.

[0370] Table B1 - Biological activity against Puccinia recondita (brown rust) of wheat, curative:

[0371]

[0372] Additional biological test examples involving fungicidal compositions comprising a mixture of components (A) and (B) as active ingredients:

[0373] Example C1 is directed against Mycosphaerella arachidis, also known as peanut brown spot pathogen (Cercospora arachidicola) (brown leaf spot) fungicidal activity

[0374] Fungal conidia from frozen storage were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and the inhibition of growth was determined photometrically at 620nm after approximately 5-6 days.

[0375] The following compound mixtures gave at least 80% control of Mycosphaerella arachidis at the rates listed in the table when compared to untreated controls which showed extensive disease development under the same conditions:

[0376] Table C1-1 - Target Mycosphaerella arachidis Antifungal Activity > 80% (% of untreated)

[0377]

[0378]

[0379]

[0380]

[0381]

[0382]

[0383]

[0384]

[0385]

[0386] Table C1-2 - Target Mycosphaerella arachidis Fungicidal activity > 80% (% untreated)

[0387]

[0388]

[0389]

[0390]

[0391]

[0392]

[0393]

[0394]

[0395]

[0396]

[0397] In this test (Mycosphaerella arachidis aka Cercospora arachidicola (peanut brown leaf spot)), the following mixture compositions gave the following disease control at the concentrations (in ppm) reported in Tables C1-3 and C1-4. Fungicidal activity was evaluated on a 100-0 scale (100 = no disease growth; 0 = complete coverage by mycelium).

[0398] Table C1-3

[0399]

[0400]

[0401] Table C1-4

[0402]

[0403]

[0404] Example C2 - Fungicidal activity against Septoria tritici (leaf blister spot)

[0405] Fungal conidia from frozen storage were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and the inhibition of growth was determined photometrically after 72 hours.

[0406] The following compound mixtures gave at least 80% control of Septoria tritici at the rates listed in the table when compared to untreated controls which showed extensive disease development under the same conditions.

[0407] Table C2-1 - Target Septoria tritici Fungicidal activity > 80% (% of untreated)

[0408]

[0409]

[0410]

[0411]

[0412]

[0413]

[0414]

[0415] Table C2-2 - Fungicidal activity against Septoria tritici > 80% (% of untreated)

[0416]

[0417]

[0418]

[0419]

[0420]

[0421]

[0422]

[0423]

[0424] In this test (Septoria tritici (leaf blister spot)), the following mixture compositions gave the following disease control at the concentrations reported in Tables C2-3 to C2-5 (in ppm). Fungicidal activity was evaluated on a 100-0 scale (100 = no disease growth; 0 = complete coverage by mycelium).

[0425] Table C2-3

[0426]

[0427]

[0428]

[0429] Table C2-4

[0430]

[0431]

[0432] Table C2-5

[0433]

[0434]

[0435]

[0436]

[0437]

[0438] Example C3 - Fungicidal activity against Septoria glycines (brown spot):

[0439] Fungal conidia harvested from fresh cultures grown on artificial media were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and the inhibition of growth was determined photometrically after 72 hours.

[0440] The following compound mixtures gave at least 80% control of Septoria glycines at the rates listed in the table when compared to untreated controls showing extensive disease development under the same conditions:

[0441] Table C3-1 - Target Septoria glycines Fungicidal activity > 80% (% untreated)

[0442]

[0443]

[0444]

[0445]

[0446]

[0447]

[0448]

[0449]

[0450]

[0451] Table C3-2 - Target Septoria glycines Fungicidal activity > 80% (% untreated)

[0452]

[0453]

[0454]

[0455]

[0456]

[0457]

[0458]

[0459]

[0460]

[0461]

[0462]

[0463] In this test (Septoria glycines (brown spot)), the following mixture compositions gave the following disease control at the concentrations (in ppm) reported in Tables C3-3 to C3-5. Fungicidal activity was evaluated on a 100-0 scale (100 = no disease growth; 0 = complete coverage by mycelium).

[0464] Table C3-3

[0465]

[0466]

[0467]

[0468]

[0469] Table C3-4

[0470]

[0471]

[0472]

[0473] Table C3-5

[0474]

[0475]

[0476]

[0477]

[0478] Example C4 - Against Glomerella lagenarium, also known as cucurbit anthracnose (Colletotrichum lagenarium) (anthracnose) fungicidal activity:

[0479] Fungal conidia from frozen storage were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and the inhibition of growth was determined photometrically at 620nm after 72 hours.

[0480] The following compound mixtures gave at least 80% control of Glomerella lagenarium at the rates listed in the table when compared to untreated controls which showed extensive disease development under the same conditions:

[0481] Table C4-1 - Targeting Glomerella lagenarium Fungicidal activity> 80% (untreated %)

[0482]

[0483]

[0484]

[0485] Table C4-2 - Targeting Glomerella lagenarium Fungicidal activity> 80% (untreated %)

[0486]

[0487]

[0488]

[0489]

[0490]

[0491]

[0492] In this test ( Glomerella lagenarium, also known as Melon Anthracnose (Colletotrichum lagenarium) ), the following mixture compositions gave the following disease control at the concentrations reported in Tables C4-3 and C4-4 (in ppm). Fungicidal activity was evaluated on a 100-0 scale (100 = no disease growth; 0 = complete coverage by mycelium).

[0493] Table C4-3

[0494]

[0495]

[0496]

[0497]

[0498] Table C4-4

[0499]

[0500]

[0501]

[0502] Example C5 - Fungicidal activity against Corynespora polymyxinii (target leaf spot)

[0503] Fungal conidia from frozen storage were mixed directly into nutrient broth (PDB potato dextrose broth). DMSO solutions of the test compounds were placed in microtiter plates (96-well format) and the nutrient broth containing the fungal spores was added thereto. These test plates were incubated at 24°C and photometrically determined after 3-4 days at 620 nm for inhibition of growth.

[0504] In this test (Corynespora polytomata), the following mixture compositions gave the following disease control at the concentrations reported in Tables C4-3 and C4-4 (in ppm). Fungicidal activity was evaluated on a 100-0 scale (100 = no disease growth; 0 = complete coverage by mycelium).

[0505] Table C5-1

[0506]

[0507]

[0508]

[0509] Example D: Preventive activity against Phakopsora pachyrhizi on soybeans

[0510] Four weeks after planting, the whole soybean plants were treated with the described active ingredients. One day after spraying, leaf disks were cut from the first three-leaved leaf. Five replicates were performed at each rate. One day after treatment, the leaf disks were inoculated with Phakopsora pachyrhizi (Asian soybean rust). 11 to 14 days after inoculation, the leaf disks were evaluated and the activity was derived from the relationship of the treated to the untreated infection test (100 = no disease, no damage to the leaves, 0 = high infection, severe damage to the leaves). The rates of active ingredients used are given in the table in g active ingredient (ai) / ha.

[0511] The results are shown in the following table:

[0512] Table D1 - Activity against Phakopsora pachyrhizi (% of untreated)

[0513]

[0514] Table D2 - Activity against Phakopsora pachyrhizi (% of untreated)

[0515]

[0516]

[0517] Table D3 - Activity against Phakopsora pachyrhizi (% of untreated)

[0518]

[0519] Table D4 - Activity against Phakopsora pachyrhizi (% of untreated)

[0520]

[0521]

[0522] Table D5 - Activity against Phakopsora pachyrhizi (% of untreated)

[0523]

[0524] Table D6 - Activity against Phakopsora pachyrhizi (% of untreated)

[0525]

[0526] Table D7 - Activity against Phakopsora pachyrhizi (% of untreated)

[0527]

[0528]

[0529] Table D8 - Activity against Phakopsora pachyrhizi (% of untreated)

[0530]

[0531] Table D9 - Activity against Phakopsora pachyrhizi (% of untreated)

[0532]

[0533] Table D10 - Activity against Phakopsora pachyrhizi (% of untreated)

[0534]

[0535] Table D11 - Activity against Phakopsora pachyrhizi (% of untreated)

[0536]

[0537] Table D12 - Activity against Phakopsora pachyrhizi (% of untreated)

[0538]

[0539]

[0540] Table D13 - Activity against Phakopsora pachyrhizi (% of untreated)

[0541]

[0542] Table D14 - Activity against Phakopsora pachyrhizi (% of untreated)

[0543]

[0544]

[0545] Table D15 - Activity against Phakopsora pachyrhizi (% of untreated)

[0546]

[0547] Table D16 - Activity against Phakopsora pachyrhizi (% of untreated)

[0548]

[0549] Table D17 - Activity against Phakopsora pachyrhizi (% of untreated)

[0550]

[0551]

[0552] Table D18 - Activity against Phakopsora pachyrhizi (% of untreated)

[0553]

[0554] Table D19 - Activity against Phakopsora pachyrhizi (% of untreated)

[0555]

[0556]

[0557] Table D20 - Activity against Phakopsora pachyrhizi (% of untreated)

[0558]

[0559] Table D21 - Activity against Phakopsora pachyrhizi (% of untreated)

[0560]

[0561]

[0562] Table D22 - Activity against Phakopsora pachyrhizi (% of untreated)

[0563]

[0564] Table D23 - Activity against Phakopsora pachyrhizi (% of untreated)

[0565]

[0566]

[0567] Table D24 - Activity against Phakopsora pachyrhizi (% of untreated)

[0568]

[0569] Table D25 - Activity against Phakopsora pachyrhizi (% of untreated)

[0570]

[0571] Table D26 - Activity against Phakopsora pachyrhizi (% of untreated)

[0572]

[0573]

[0574] Table D27 - Activity against Phakopsora pachyrhizi (% of untreated)

[0575]

Claims

1. A fungicidal composition comprising as active ingredients a mixture of components (A) and (B), wherein component (A) is: (Z)-2-(5-Cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.02), or (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester (Compound X.04); or an agronomically acceptable salt thereof; and Component (B) is a compound selected from N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide or [(1S,2S)-1-methyl-2-(o-tolyl)propyl](2S)-2-[(4-methoxy-3-propionyloxy-pyridine-2-carbonyl)amino]propanoate, in, The weight ratio of component (A) to component (B) is from 100:1 to 1:

100.

2. The fungicidal composition according to claim 1, in, The weight ratio of component (A) to component (B) is from 20:1 to 1:

40.

3. The fungicidal composition according to claim 1, in, The weight ratio of component (A) to component (B) is from 12:1 to 1:

25.

4. The fungicidal composition according to claim 1, in, The weight ratio of component (A) to component (B) is from 5:1 to 1:

15.

5. The fungicidal composition according to claim 1, in, The weight ratio of component (A) to component (B) is from 2:1 to 1:

5.

6. The fungicidal composition according to claim 1, in, The composition comprises one or more additional pesticides selected from the group consisting of: A fungicide, wherein the fungicide is selected from the group consisting of thiabendazim, fluazinam, benzovinflumazole, fluopicolide, bensulfuron, bensulfuron-M (bensulfuron-M), furalaxyl, metalaxyl, metalaxyl-M (metalaxyl-M), dodesin, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine , acetylthiocarb, 3'-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]acetyl-2',6'-dimethylaniline (imycyl), cyprodinil, pyraclostrobin, pyraclostrobin, dithianon, aureomycin, blasticidin-S, biphenyl, dimethoate, chloranil, hexachlorobenzene, pentachloronitrobenzene, tetrachloronitrobenzene (TCNB), methyl tolclofos, mefenamic acid, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopyram, thiocyanate, sulfamethoxam, benomyl, carbendazim, carbendazim hydrochloride, clofenazole, wheat spike, thiabendazole, methyl thiophanate, benzylthiocarb, thiophanate-methyl ... Benzene, chloranil, methoxybenzene (IKF-309), acibenzolar-S-methyl, pyraclostrobin (KIF-7767), butylamine, 3-iodo-2-propynyl n-butylcarbamate (IPBC), iodopropynyl butylcarbamate (isopropyl butylcarbamate), isopropyl butylcarbamate (iodopropynyl butylcarbamate), tetrazolylpyramine, polycarbamate, propamocarb, trifluoromethoxycarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, dichlorocyanamide, N-[(5-chloro-2-isopropyl-phenyl) [(2-isopropylphenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methyl-pyrazole-4-carboxamide, cyclopropane, thiocarbamide, flumorph, quinoline copper, cymoxanil, cyproconazole, cyazolin, fluthiazolin, thiophanate-methyl ...6H)-tetraketone, thiram oxide, mancozeb, ferram, mancozeb, maneb, methamphetamine, metiram, metiram-zinc, mancozeb, methyl propineb, thiram, sodium thiocarb, mancozeb, zinc thiram, dimethyl disulfide, pyraclostrobin, fosetyl, fosetyl-aluminum (pyraclostrobin), methyl bromide, iodomethane, methyl isothiocyanate, cyclamic acid, furamide, validamycin, streptomycin, (2RS)-2-bromo-2-(bromomethyl) glutaronitrile (bromothionil), docodin, dodecylguanidine acetate, biguanide salt, biguanide octylamine, biguanide octylamine triacetate, 2,4-D, 2,4-DB, kasugamycin, mefenamic acid, cyclamic acid, oxadipamide, oxadipamide, oxadipamide sulfate, oxadiazole, pyraclostrobin, imazalil Amine, triflumizole, imidacloprid, Bordeaux mixture, calcium polysulfide, copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper quinoline, copper silicate, copper sulfate, tall copper, cuprous oxide, sulfur, carbaryl, rice blast phthalide (tetrachlorophthalide), pyraclostrobin (bacterium), fluthiazolinone, flutrioxetine, dimethomorph, KSF-1002, antibacterial chloranil, oxadiazine, butyl fenpropimorph, tridecanol, dodecanol, ethotripsy, triphenyltin acetate, triphenyltin hydroxide, carboxin, carboxin oxide, dithiocarb, oxadiazine, m-phenylphenol, p-phenylphenol, tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propane- 2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propane-2-ol, cyfluthrin, furamide, oxadone, flutolanil, oxadiazine, isoproterenol, fenthiocarb, fludioxonil, pencuronium, kewensan, isoproterenol, chloranil, phosphoric acid, chlorothalonil, captan, captan, chloranil, chloranil, fenpropidin, powdery mildew, osthole, 1-methylcyclopropene, 4-CPA, chlormequat, pyridazine, 2,4-dichloropropionic acid, thiamethoxam, endorphin, ethephon, flumetrazone, chlorpyrifos, gibberellic acid, gibberellin, oxadiazine, maleic hydrazide, auxotropin, naphthamide, paclobutrazol, prohexadione, prohexadione calcium, thiadiazole, defoliation phosphorus (tributyl trithiophosphate), anti-invert acid, uniconazole, α- Naphthaleneacetic acid, polyoxin D (polyoxin), BLAD, chitosan, cyanamide, folpet, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bixafen, flupyraclostrobin, furazolidone, pyraclostrobin, pentofenpyraclostrobin, penthiopyraclostrobin, fluazole cyclam, aminopyraclostrobin, pyraclostrobin, pyraclostrobin, boscalid, flupyraclostrobin, difluoline, chlorpyrifos, 5-fluoro-2-(p-tolylmethoxy)pyrimidine-4-amine, pyrimidine, myclobutanil, pyroquinone, propoxyquin, ethoxyquin, quinoxyfen, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline, 4,4-difluoro-3,3-Dimethyl-1-(3-quinolyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazine, isobutylethoxyquinoline, oxolinic acid, mitoxantrone, spiroxabiodinium, (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide, (Mandesbin), azoxystrobin, syringostyrin, oxazolidinone, enoxastrobin, pyrotin, pyrotin, enoxastrobin, flutoxin, fluoxastrobin, oxazolidinone, mandesbin, fenoxystrobin, formoxanil, oxazolidinone, picoxystrobin, pyraclostrobin, pyraclostrobin, chlorpyrifos, trifloxystrobin , indazolesulfamide, bacteriostatic, tolylfluanid, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridinyl]carbamate, dazomethon, isothiopyrad, thiopyrad, thiofuran, benzthiocyanate (TCMTB), thiopyrad, benzylfuramid, antifungal, tricyclazole, (.+-.)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (cyclaconazole), 1-(5-bromo-2-pyridinyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propan-2-ol, 2-(1-tert-butyl)-1-(2-chlorophenyl) 1,2,4-triazol-1-yl)-3-(1,2,4-triazol-1-yl)-propane-2-ol (TCDP), (N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridinyl]-N-ethyl-N-methyl-formamidine), azaconazole, bifenthrinol (bifenthrinol), bramconazole, climbazole, cyproconazole, difenoconazole, dimeconazole, diniconazole, diniconazole-M, fluoxiconazole, eticonazole, nitrobenzene, fluquinconazole, flusilazole, flutriafol, hexaconazole, imidazole, cyproconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, clofoconazole, silfluazole, tebuconazole, tetraconazole, triadimefon, triadimenol, imidazolin, trichlorfonazole, 2-[[(1R,5S)-5-[( 4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazole-3-thione, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl]-4H-1,2,4-triazole-3-thione, pyraclostrobin, isopropanil, valeramide, 2-benzyl-4-chlorophenol (benzyl chlorophenol), allyl alcohol, pyrazolone, benzalkonium chloride, chloropicrin, cresol, dalaside, dichlorophen (dichlorophenol), avenate, pyridinium bisthiocarbamate, N-(2-chlorobenzoylethyl)-hexamethylenetetramine chloride, NNF-0721, octhiocarbazone, epoxysulfuron, plant extracts containing tea tree oil Melaleuca alternifolia (Timorex Gold, TM ), biostimulants containing organic carbon, nutrients and amino acids (Quantis TM ), propaneamidine and propionic acid; or Insecticide, the insecticide is selected from avermectin, acetamiprid, sulfamethoxam (S-1955), avermectin, azadirachtin, methyl azinphos-methyl, bifenthrin, bifenazate, bromofenapyr, buprofezin, carbofuran, batan, chlorfenapyr (DPX-E2Y45), chlorfenapyr, chlorpyrifos, methyl chlorpyrifos, chlorfenapyr, clothianidin, chlorfenapyr ... Mite ester, cyfluthrin, β-cyfluthrin, tri-cyhalothrin, λ-tri-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, tetrafluthrin, dimethoate, dinotefuran, benzylpezil, emamectin, endosulfan, cypermethrin, ethiprole, fenthiocarb, fenoxycarb, cypermethrin, cypermethrin, fipronil, flonicamid, flubendiamide , flucythrinate, τ-fluvalinate, cypermethrin (UR-50701), flufenoxuron, flufenoxim, chlorfenapyr, hexaflumuron, hydrazone, imidacloprid, indoxacarb, isoflavone, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, methoxyfluthrin, monocrotophos, methoxyfenozide, nitenpyram, thiazole, dimethoate benzylfluanid, nitrothion (XDE-007), oxamyl, parathion, methyl parathion, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, pymetrozine, pyraclostrobin, pyrethrins, pyralidin, flufenac, pyraclostrobin, pyrimethrin, pyridalyl, flufenac, pyraclostrobin, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN 2060), spirotetramat, thioprofos, tebuconazole ... a bactericide selected from streptomycin; or Acaricide, wherein the acaricide is selected from amitraz, chloranil, ethyl chloranil, cypermethrin, cypermethrin, fenbutatin, cypermethrin, fenbutatin, cypermethrin, fenpyrad, hexathiapiprolin, propargite, pyridaben and cypermethrin; or The biological agent is selected from Bacillus thuringiensis, Bacillus thuringiensis delta endotoxin, baculovirus, and insect pathogenic bacteria, viruses and fungi.

7. The fungicidal composition according to claim 1, in, The composition further comprises an agriculturally acceptable carrier, and optionally a surfactant and / or a formulation adjuvant.

8. A method for controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi, on useful plants or their propagation material, which method comprises applying a fungicidal composition as defined in any one of claims 1 to 7 to the useful plants, their locus or their propagation material.

9. The method of claim 8, wherein the composition components (A) and (B) are applied in a sequential manner.

Citation Information

Patent Citations

  • Use of agrochemical mixtures for increasing the health of plant

    CN102458111A

  • Fungicides

    EP0212859A2

  • Acrylic acid derivatives, use of the same and intermediates for the preparation thereof

    WO2001000562A1

  • METHOD OF CONTROLLING SOYBEAN RUST FUNGUS THAT IS RESISTANT TO Qo INHIBITORS

    WO2020027214A1

  • Fungicidal compounds

    WO2020193387A1